|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of ABCB11 mRNA |
CTD |
PMID:31052254 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression |
ISO |
Cannabidiol results in increased expression of ABCB1A mRNA |
CTD |
PMID:31052254 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of ABCB4 mRNA |
CTD |
PMID:31052254 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcb6 |
ATP binding cassette subfamily B member 6 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of ABCB6 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 9:76,668,554...76,677,263
Ensembl chr 9:76,668,554...76,676,924
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
decreases activity |
ISO |
Cannabidiol results in decreased activity of ABCC1 protein |
CTD |
PMID:18619955 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases expression |
ISO |
Cannabidiol results in increased expression of ABCC2 mRNA |
CTD |
PMID:31052254 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
increases expression |
ISO |
Cannabidiol results in increased expression of ABCC3 mRNA |
CTD |
PMID:31052254 PMID:31518892 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abhd12 |
abhydrolase domain containing 12, lysophospholipase |
increases expression |
ISO |
Cannabidiol results in increased expression of ABHD12 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 3:139,659,315...139,719,529
Ensembl chr 3:139,659,317...139,719,564
|
|
G |
Abhd3 |
abhydrolase domain containing 3, phospholipase |
increases expression |
ISO |
Cannabidiol results in increased expression of ABHD3 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr18:1,723,203...1,778,488
Ensembl chr18:1,720,718...1,803,428
|
|
G |
Abl2 |
ABL proto-oncogene 2, non-receptor tyrosine kinase |
multiple interactions |
ISO |
[Dronabinol co-treated with Cannabidiol] results in increased expression of ABL2 mRNA |
CTD |
PMID:26504004 |
|
NCBI chr13:68,673,702...68,839,742
Ensembl chr13:68,673,722...68,839,742
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [Ethanol results in increased expression of ACACA mRNA]; Cannabidiol inhibits the reaction [Ethanol results in increased expression of ACACA protein] |
CTD |
PMID:28935932 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acadm |
acyl-CoA dehydrogenase medium chain |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [Ethanol results in decreased expression of ACADM mRNA] |
CTD |
PMID:28935932 |
|
NCBI chr 2:242,858,865...242,883,036
Ensembl chr 2:242,858,865...242,883,147
|
|
G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
decreases expression |
ISO |
Cannabidiol results in decreased expression of ACADVL protein |
CTD |
PMID:34122009 |
|
NCBI chr10:54,732,875...54,738,102
Ensembl chr10:54,732,469...54,738,075
|
|
G |
Ace |
angiotensin I converting enzyme |
increases expression |
ISO |
Cannabidiol results in increased expression of ACE1 mRNA |
CTD |
PMID:28025562 |
|
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Acin1 |
apoptotic chromatin condensation inducer 1 |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in decreased expression of ACIN1 mRNA |
CTD |
PMID:30096889 |
|
NCBI chr15:28,102,112...28,147,001
Ensembl chr15:28,102,112...28,147,001
|
|
G |
Actn1 |
actinin, alpha 1 |
affects methylation |
EXP |
Cannabidiol affects the methylation of ACTN1 gene |
CTD |
PMID:30521419 |
|
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
|
|
G |
Actr3 |
actin related protein 3 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of ACTR3 protein |
CTD |
PMID:34122009 |
|
NCBI chr13:36,800,739...36,843,837
Ensembl chr13:36,800,093...36,844,124
|
|
G |
Actr5 |
actin related protein 5 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of ACTR5 protein |
CTD |
PMID:34122009 |
|
NCBI chr 3:147,282,461...147,296,110
Ensembl chr 3:147,282,624...147,296,110
|
|
G |
Actrt3 |
actin-related protein T3 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of ACTRT3 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 2:112,799,061...112,801,021
Ensembl chr 2:112,799,011...112,801,075
|
|
G |
Adam9 |
ADAM metallopeptidase domain 9 |
increases expression |
ISO |
Cannabidiol results in increased expression of ADAM9 mRNA |
CTD |
PMID:28025562 |
|
NCBI chr16:67,022,538...67,101,647
Ensembl chr16:67,022,655...67,100,917
|
|
G |
Adcy5 |
adenylate cyclase 5 |
increases expression |
ISO |
Cannabidiol results in increased expression of ADCY5 mRNA |
CTD |
PMID:33019509 |
|
NCBI chr11:65,471,612...65,618,877
Ensembl chr11:65,471,612...65,618,974
|
|
G |
Adcy9 |
adenylate cyclase 9 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of ADCY9 mRNA |
CTD |
PMID:33019509 |
|
NCBI chr10:11,138,966...11,262,067
Ensembl chr10:11,139,446...11,262,066
|
|
G |
Adh7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
increases expression |
ISO |
Cannabidiol results in increased expression of ADH7 mRNA |
CTD |
PMID:31518892 |
|
NCBI chr 2:226,748,724...226,763,183
Ensembl chr 2:226,741,788...226,763,182
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
multiple interactions |
ISO |
Cannabidiol analog inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein] |
CTD |
PMID:30382123 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adipor1 |
adiponectin receptor 1 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [Ethanol results in decreased expression of ADIPOR1 mRNA] |
CTD |
PMID:28935932 |
|
NCBI chr13:45,859,461...45,879,248
Ensembl chr13:45,859,533...45,879,241
|
|
G |
Adm |
adrenomedullin |
increases expression |
ISO |
Cannabidiol results in increased expression of ADM mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adrb1 |
adrenoceptor beta 1 |
decreases expression |
EXP |
Cannabidiol results in decreased expression of ADRB1 protein |
CTD |
PMID:33338514 |
|
NCBI chr 1:255,772,217...255,773,617
Ensembl chr 1:255,771,597...255,807,259
|
|
G |
Aftph |
aftiphilin |
increases expression |
ISO |
Cannabidiol results in increased expression of AFTPH mRNA |
CTD |
PMID:27918106 |
|
NCBI chr14:94,871,429...94,925,625
Ensembl chr14:94,871,429...94,925,376
|
|
G |
Agtrap |
angiotensin II receptor-associated protein |
increases expression |
ISO |
Cannabidiol results in increased expression of AGTRAP mRNA |
CTD |
PMID:30742662 |
|
NCBI chr 5:158,507,427...158,519,036
Ensembl chr 5:158,508,749...158,519,036
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
AHR protein affects the reaction [Cannabidiol results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:26187180 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aicda |
activation-induced cytidine deaminase |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of AICDA mRNA [lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in decreased expression of AICDA mRNA |
CTD |
PMID:30742662 |
|
NCBI chr 4:155,774,132...155,783,972
Ensembl chr 4:155,774,132...155,783,972
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
multiple interactions |
EXP |
Cannabidiol inhibits the reaction [Ketamine results in decreased expression of AIF1 mRNA] |
CTD |
PMID:31823199 |
|
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of AIFM1 mRNA |
CTD |
PMID:30096889 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Aimp1 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [TNF protein results in decreased expression of AIMP1 mRNA] |
CTD |
PMID:31250491 |
|
NCBI chr 2:221,151,907...221,175,458
Ensembl chr 2:221,151,904...221,175,728
|
|
G |
Ak1 |
adenylate kinase 1 |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of AK1 protein |
CTD |
PMID:34122009 |
|
NCBI chr 3:15,912,431...15,923,045
Ensembl chr 3:15,912,485...15,923,041
|
|
G |
Akr1b7 |
aldo-keto reductase family 1, member B7 |
increases expression |
ISO |
Cannabidiol results in increased expression of AKR1B7 mRNA |
CTD |
PMID:21542829 |
|
NCBI chr 4:63,053,560...63,100,934
Ensembl chr 4:63,076,800...63,089,502
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation increases expression multiple interactions affects expression decreases expression increases phosphorylation |
ISO |
Cannabidiol results in decreased phosphorylation of AKT1 protein Cannabidiol results in increased expression of AKT1 mRNA 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Cannabidiol results in decreased phosphorylation of AKT1 protein]; [Cannabidiol co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in decreased phosphorylation of AKT1 protein; [Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of AKT1 mRNA; AM 251 inhibits the reaction [Cannabidiol results in increased phosphorylation of AKT1 protein]; Cannabidiol promotes the reaction [SB 203580 results in decreased phosphorylation of AKT1 protein]; Cannabidiol results in decreased phosphorylation of and results in decreased expression of AKT1 protein modified form; Chloroquine affects the reaction [Cannabidiol results in decreased phosphorylation of AKT1 protein]; tanespimycin affects the reaction [Cannabidiol affects the expression of AKT1 protein]; VER 155008 affects the reaction [Cannabidiol affects the expression of AKT1 protein] Cannabidiol results in decreased expression of AKT1 mRNA |
CTD |
PMID:26504004 PMID:27932991 PMID:28025562 PMID:28392768 PMID:30713602 PMID:31801206 PMID:32060308 PMID:32992648 PMID:33019509 PMID:33817834 PMID:34575494 More...
|
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Akt1s1 |
AKT1 substrate 1 |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of AKT1S1 mRNA |
CTD |
PMID:30096889 |
|
NCBI chr 1:95,333,186...95,339,678
Ensembl chr 1:95,332,898...95,339,677
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
multiple interactions |
ISO |
[Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of AKT2 mRNA |
CTD |
PMID:32992648 |
|
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
|
|
G |
Alcam |
activated leukocyte cell adhesion molecule |
decreases expression |
ISO |
Cannabidiol results in decreased expression of ALCAM mRNA |
CTD |
PMID:27932991 |
|
NCBI chr11:48,336,123...48,536,296
Ensembl chr11:48,336,169...48,537,954
|
|
G |
Aldh9a1 |
aldehyde dehydrogenase 9 family, member A1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of ALDH9A1 protein |
CTD |
PMID:34122009 |
|
NCBI chr13:79,505,738...79,522,539
Ensembl chr13:79,505,695...79,540,568
|
|
G |
Aldoc |
aldolase, fructose-bisphosphate C |
decreases expression |
ISO |
Cannabidiol results in decreased expression of ALDOC protein |
CTD |
PMID:34122009 |
|
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
|
|
G |
Alg6 |
ALG6, alpha-1,3-glucosyltransferase |
decreases expression |
ISO |
Cannabidiol results in decreased expression of ALG6 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 5:114,404,972...114,454,440
Ensembl chr 5:114,405,010...114,454,439
|
|
G |
Aloxe3 |
arachidonate lipoxygenase 3 |
increases expression |
ISO |
Cannabidiol results in increased expression of ALOXE3 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr10:53,830,219...53,854,328
Ensembl chr10:53,831,264...53,854,328
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
increases expression |
ISO |
Cannabidiol results in increased expression of ALPL mRNA |
CTD |
PMID:33872753 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Angpt1 |
angiopoietin 1 |
increases secretion |
ISO |
Cannabidiol results in increased secretion of ANGPT1 protein |
CTD |
PMID:32656944 |
|
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
|
|
G |
Angptl3 |
angiopoietin-like 3 |
multiple interactions |
ISO |
Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of ANGPTL3 protein] |
CTD |
PMID:30825431 |
|
NCBI chr 5:113,703,007...113,710,044
Ensembl chr 5:113,703,012...113,709,957
|
|
G |
Angptl6 |
angiopoietin-like 6 |
increases expression |
ISO |
Cannabidiol results in increased expression of ANGPTL6 mRNA |
CTD |
PMID:21542829 |
|
NCBI chr 8:19,413,617...19,419,925
Ensembl chr 8:19,413,619...19,419,925
|
|
G |
Anp32b |
acidic nuclear phosphoprotein 32 family member B |
increases expression |
ISO |
Cannabidiol results in increased expression of ANP32B mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 5:60,743,077...60,765,726
Ensembl chr 5:60,743,443...60,765,717
|
|
G |
Anpep |
alanyl aminopeptidase, membrane |
increases expression |
ISO |
Cannabidiol results in increased expression of ANPEP mRNA |
CTD |
PMID:27932991 |
|
NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:133,767,332...133,785,789
|
|
G |
Ap1m1 |
adaptor related protein complex 1 subunit mu 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of AP1M1 protein |
CTD |
PMID:34122009 |
|
NCBI chr16:17,586,886...17,602,410
Ensembl chr16:17,584,730...17,602,403
|
|
G |
Ap3b1 |
adaptor related protein complex 3 subunit beta 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of AP3B1 protein |
CTD |
PMID:34122009 |
|
NCBI chr 2:25,600,069...25,800,937
Ensembl chr 2:25,600,040...25,800,935
|
|
G |
Ap4e1 |
adaptor related protein complex 4 subunit epsilon 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of AP4E1 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 3:114,272,997...114,339,484
Ensembl chr 3:114,272,956...114,336,752
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
multiple interactions increases expression decreases expression |
ISO |
[Cannabidiol co-treated with moringin] results in decreased expression of APAF1 mRNA Cannabidiol results in increased expression of APAF1 protein Cannabidiol results in decreased expression of APAF1 mRNA |
CTD |
PMID:27932991 PMID:30096889 PMID:31349651 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Apbb3 |
amyloid beta precursor protein binding family B member 3 |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in decreased expression of APBB3 mRNA |
CTD |
PMID:30096889 |
|
NCBI chr18:28,273,168...28,280,347
Ensembl chr18:28,270,545...28,280,094
|
|
G |
Apc2 |
APC regulator of WNT signaling pathway 2 |
affects methylation |
EXP |
Cannabidiol affects the methylation of APC2 gene |
CTD |
PMID:30521419 |
|
NCBI chr 7:9,392,336...9,414,364
Ensembl chr 7:9,392,336...9,414,310
|
|
G |
Aph1a |
aph-1 homolog A, gamma secretase subunit |
decreases expression |
ISO |
Cannabidiol results in decreased expression of APH1A mRNA |
CTD |
PMID:28025562 |
|
NCBI chr 2:183,437,676...183,443,113
Ensembl chr 2:183,438,434...183,441,955
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [APP alternative form results in increased expression of IL6 mRNA] [Cannabidiol co-treated with moringin] results in decreased expression of APP mRNA; [Dronabinol co-treated with Cannabidiol] inhibits the reaction [[APP gene mutant form co-treated with PSEN1 gene mutant form] results in decreased expression of GABRA1 protein]; [Dronabinol co-treated with Cannabidiol] results in decreased susceptibility to [[APP gene mutant form co-treated with PSEN1 gene mutant form] results in decreased expression of GRIA2 protein]; [Dronabinol co-treated with Cannabidiol] results in decreased susceptibility to [[APP gene mutant form co-treated with PSEN1 gene mutant form] results in decreased expression of SNAP25 protein]; [Dronabinol co-treated with Cannabidiol] results in decreased susceptibility to [[APP gene mutant form co-treated with PSEN1 gene mutant form] results in increased expression of DLG4 protein]; [Dronabinol co-treated with Cannabidiol] results in decreased susceptibility to [APP gene mutant form co-treated with PSEN1 gene mutant form] |
CTD |
PMID:21350020 PMID:27567873 PMID:30096889 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Aqp1 |
aquaporin 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of AQP1 mRNA |
CTD |
PMID:27932991 |
|
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
|
|
G |
Aqp3 |
aquaporin 3 (Gill blood group) |
multiple interactions increases expression |
ISO |
[Cannabidiol co-treated with TNF protein co-treated with IFNG protein] results in increased expression of AQP3 mRNA; Cannabidiol inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased expression of AQP3 mRNA] Cannabidiol results in increased expression of AQP3 mRNA; Cannabidiol results in increased expression of AQP3 protein |
CTD |
PMID:31054246 PMID:34577578 |
|
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
|
|
G |
Aqp4 |
aquaporin 4 |
affects expression |
ISO |
Cannabidiol affects the expression of AQP4 mRNA |
CTD |
PMID:31054246 |
|
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
|
|
G |
Aqp9 |
aquaporin 9 |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of AQP9 mRNA [lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in increased expression of AQP9 mRNA |
CTD |
PMID:21542829 PMID:30742662 |
|
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
|
|
G |
Areg |
amphiregulin |
increases expression |
ISO |
Cannabidiol results in increased expression of AREG mRNA |
CTD |
PMID:33244087 PMID:36519830 |
|
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Arg1 |
arginase 1 |
multiple interactions |
ISO |
Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of ARG1 protein] |
CTD |
PMID:30825431 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arg2 |
arginase 2 |
increases expression |
ISO |
Cannabidiol results in increased expression of ARG2 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
|
|
G |
Arglu1 |
arginine and glutamate rich 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of ARGLU1 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr16:80,753,300...80,777,350
Ensembl chr16:80,753,315...80,777,349
|
|
G |
Arl1 |
ADP-ribosylation factor like GTPase 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of ARL1 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 7:23,120,004...23,131,173
Ensembl chr 7:23,119,589...23,131,898
|
|
G |
Arpc1a |
actin related protein 2/3 complex, subunit 1A |
affects methylation |
EXP |
Cannabidiol affects the methylation of ARPC1A gene |
CTD |
PMID:30521419 |
|
NCBI chr12:9,502,496...9,525,304
Ensembl chr12:9,502,501...9,525,330
|
|
G |
Arrb2 |
arrestin, beta 2 |
affects methylation |
EXP |
Cannabidiol affects the methylation of ARRB2 gene |
CTD |
PMID:30521419 |
|
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
|
|
G |
Arrdc3 |
arrestin domain containing 3 |
increases expression |
ISO |
Cannabidiol results in increased expression of ARRDC3 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 2:11,137,443...11,149,978
Ensembl chr 2:11,137,460...11,149,978
|
|
G |
Asah1 |
N-acylsphingosine amidohydrolase 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of ASAH1 mRNA |
CTD |
PMID:31052254 |
|
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
|
|
G |
Asb2 |
ankyrin repeat and SOCS box-containing 2 |
increases expression |
ISO |
Cannabidiol results in increased expression of ASB2 mRNA |
CTD |
PMID:27256343 |
|
NCBI chr 6:122,474,754...122,511,014
Ensembl chr 6:122,474,756...122,510,854
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
multiple interactions increases expression |
ISO |
[Dronabinol co-treated with Cannabidiol] results in increased expression of ASNS mRNA Cannabidiol results in increased expression of ASNS mRNA |
CTD |
PMID:26504004 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Asph |
aspartate-beta-hydroxylase |
increases expression |
ISO |
Cannabidiol results in increased expression of ASPH protein |
CTD |
PMID:34122009 |
|
NCBI chr 5:22,603,879...22,814,107
Ensembl chr 5:22,603,486...22,813,876
|
|
G |
Atad5 |
ATPase family, AAA domain containing 5 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of ATAD5 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr10:65,070,682...65,118,489
Ensembl chr10:65,070,689...65,117,845
|
|
G |
Atat1 |
alpha tubulin acetyltransferase 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of ATAT1 mRNA |
CTD |
PMID:27932991 |
|
NCBI chr20:2,844,595...2,857,809
Ensembl chr20:2,844,616...2,861,964
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of ATF3 mRNA Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of ATF3 mRNA] [Dronabinol co-treated with Cannabidiol] results in increased expression of ATF3 mRNA |
CTD |
PMID:21542829 PMID:26504004 PMID:27256343 PMID:33244087 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atf4 |
activating transcription factor 4 |
increases expression |
ISO |
Cannabidiol results in increased expression of ATF4 mRNA |
CTD |
PMID:21542829 PMID:30307084 PMID:33019509 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf5 |
activating transcription factor 5 |
increases expression |
ISO |
Cannabidiol results in increased expression of ATF5 mRNA |
CTD |
PMID:21542829 PMID:30307084 |
|
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
|
|
G |
Atg12 |
autophagy related 12 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [DMD gene mutant form results in decreased expression of ATG12 mRNA] |
CTD |
PMID:30074247 |
|
NCBI chr18:39,452,247...39,462,424
Ensembl chr18:39,452,191...39,462,418
|
|
G |
Atg4a |
autophagy related 4A, cysteine peptidase |
multiple interactions |
ISO |
[PSEN1 protein affects the susceptibility to Cannabidiol] which affects the expression of ATG4A mRNA |
CTD |
PMID:33096116 |
|
NCBI chr X:104,665,345...104,765,271
Ensembl chr X:104,665,345...104,765,268
|
|
G |
Atg4b |
autophagy related 4B, cysteine peptidase |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [DMD gene mutant form results in decreased expression of ATG4B mRNA] |
CTD |
PMID:30074247 |
|
NCBI chr 9:94,282,417...94,314,109
Ensembl chr 9:94,282,509...94,314,103
|
|
G |
Atm |
ATM serine/threonine kinase |
multiple interactions increases expression |
ISO |
[Cannabidiol co-treated with moringin] results in decreased expression of ATM mRNA Cannabidiol results in increased expression of ATM protein |
CTD |
PMID:30096889 PMID:31349651 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atp1a1 |
ATPase Na+/K+ transporting subunit alpha 1 |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of ATP1A1 mRNA |
CTD |
PMID:30096889 |
|
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
|
|
G |
Atp2a3 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 |
increases expression |
ISO |
Cannabidiol results in increased expression of ATP2A3 mRNA |
CTD |
PMID:21542829 |
|
NCBI chr10:57,581,742...57,612,758
Ensembl chr10:57,582,128...57,612,748
|
|
G |
Atp5f1a |
ATP synthase F1 subunit alpha |
decreases expression |
ISO |
Cannabidiol results in decreased expression of ATP5A1 protein |
CTD |
PMID:34122009 |
|
NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794
|
|
G |
Atp5po |
ATP synthase peripheral stalk subunit OSCP |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in increased expression of ATP5O protein |
CTD |
PMID:34122009 |
|
NCBI chr11:31,165,218...31,171,530
Ensembl chr11:31,165,217...31,171,592
|
|
G |
Atp6v1a |
ATPase H+ transporting V1 subunit A |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of ATP6V1A protein |
CTD |
PMID:34122009 |
|
NCBI chr11:56,561,444...56,614,694
Ensembl chr11:56,560,974...56,614,694
|
|
G |
Atp8b1 |
ATPase phospholipid transporting 8B1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of ATP8B1 mRNA |
CTD |
PMID:31052254 |
|
NCBI chr18:58,016,382...58,157,213
Ensembl chr18:58,018,268...58,157,396
|
|
G |
Aurkb |
aurora kinase B |
increases expression |
ISO |
Cannabidiol results in increased expression of AURKB mRNA |
CTD |
PMID:27918106 |
|
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
|
|
G |
Avil |
advillin |
increases expression |
ISO |
Cannabidiol results in increased expression of AVIL mRNA |
CTD |
PMID:21542829 |
|
NCBI chr 7:62,825,459...62,844,103
Ensembl chr 7:62,826,025...62,844,071
|
|
G |
Avpr1a |
arginine vasopressin receptor 1A |
decreases expression |
ISO |
Cannabidiol results in decreased expression of AVPR1A mRNA |
CTD |
PMID:31052254 |
|
NCBI chr 7:58,114,306...58,118,230
Ensembl chr 7:58,114,284...58,122,215
|
|
G |
Axin2 |
axin 2 |
affects methylation |
EXP |
Cannabidiol affects the methylation of AXIN2 gene |
CTD |
PMID:30521419 |
|
NCBI chr10:93,893,830...93,927,042
Ensembl chr10:93,899,245...93,926,231
|
|
G |
Axl |
Axl receptor tyrosine kinase |
increases expression |
ISO |
Cannabidiol results in increased expression of AXL mRNA |
CTD |
PMID:30742662 |
|
NCBI chr 1:81,265,656...81,296,278
Ensembl chr 1:81,265,088...81,296,265
|
|
G |
Azi2 |
5-azacytidine induced 2 |
increases expression |
ISO |
Cannabidiol results in increased expression of AZI2 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 8:117,773,248...117,797,844
Ensembl chr 8:117,773,279...117,797,847
|
|
G |
B2m |
beta-2 microglobulin |
decreases expression |
ISO |
Cannabidiol results in decreased expression of B2M mRNA |
CTD |
PMID:31052254 |
|
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
|
|
G |
Bace1 |
beta-secretase 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of BACE1 mRNA |
CTD |
PMID:28025562 |
|
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
|
|
G |
Bach1 |
BTB domain and CNC homolog 1 |
increases expression multiple interactions decreases expression |
ISO |
Cannabidiol results in increased expression of BACH1 mRNA [lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in increased expression of BACH1 mRNA BACH1 protein affects the reaction [Cannabidiol results in increased expression of HMOX1 mRNA]; BACH1 protein affects the reaction [Cannabidiol results in increased expression of HMOX1 protein]; leptomycin B inhibits the reaction [Cannabidiol results in decreased expression of BACH1 protein] |
CTD |
PMID:30742662 PMID:31518892 |
|
NCBI chr11:26,939,429...26,974,876
Ensembl chr11:26,939,480...26,972,447
|
|
G |
Bad |
BCL2-associated agonist of cell death |
increases expression multiple interactions decreases expression |
ISO |
Cannabidiol results in increased expression of BAD protein [Cannabidiol co-treated with moringin] results in decreased expression of BAD mRNA Cannabidiol results in decreased expression of BAD mRNA |
CTD |
PMID:27932991 PMID:30096889 PMID:31349651 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression decreases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of BAX mRNA; Cannabidiol results in increased expression of BAX protein Cannabidiol results in decreased expression of BAX protein [Cannabidiol co-treated with moringin] results in decreased expression of BAX mRNA; iodopravadoline inhibits the reaction [Cannabidiol results in decreased expression of BAX protein]; Rimonabant inhibits the reaction [Cannabidiol results in decreased expression of BAX protein] |
CTD |
PMID:27932991 PMID:30096889 PMID:31349651 PMID:33244087 PMID:34575494 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Baz1b |
bromodomain adjacent to zinc finger domain, 1B |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of BAZ1B protein |
CTD |
PMID:34122009 |
|
NCBI chr12:21,431,985...21,489,956
Ensembl chr12:21,431,985...21,490,426
|
|
G |
Bbs5 |
Bardet-Biedl syndrome 5 |
increases expression |
ISO |
Cannabidiol results in increased expression of BBS5 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 3:54,410,429...54,431,831
Ensembl chr 3:54,410,775...54,431,829
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression increases expression |
EXP ISO |
Cannabidiol inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] Cannabidiol results in decreased expression of BCL2 mRNA; Cannabidiol results in decreased expression of BCL2 protein Cannabidiol results in increased expression of BCL2 protein |
CTD |
PMID:27430346 PMID:27932991 PMID:31349651 PMID:33244087 PMID:34575494 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of BCL2A1 mRNA |
CTD |
PMID:30096889 |
|
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
increases expression multiple interactions decreases expression |
ISO |
Cannabidiol results in increased expression of BCL2L1 mRNA [Cannabidiol co-treated with moringin] results in increased expression of BCL2L1 mRNA; [Cannabidiol results in increased expression of MIR1972-2 mRNA] which results in decreased expression of BCL2L1 mRNA Cannabidiol results in decreased expression of BCL2L1 mRNA |
CTD |
PMID:30096889 PMID:30713602 PMID:33019509 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bcl2l13 |
Bcl2-like 13 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of BCL2L13 mRNA |
CTD |
PMID:27932991 |
|
NCBI chr 4:154,056,116...154,112,890
Ensembl chr 4:154,056,127...154,108,985
|
|
G |
Bcl7b |
BAF chromatin remodeling complex subunit BCL7B |
decreases expression |
ISO |
Cannabidiol results in decreased expression of BCL7B mRNA |
CTD |
PMID:27918106 PMID:27932991 |
|
NCBI chr12:21,496,856...21,510,202
Ensembl chr12:21,496,856...21,510,202
|
|
G |
Bcl9 |
BCL9, transcription coactivator |
increases expression |
ISO |
Cannabidiol results in increased expression of BCL9 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 2:184,760,616...184,846,261
Ensembl chr 2:184,760,618...184,786,435
|
|
G |
Bcorl1 |
BCL6 co-repressor-like 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of BCORL1 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr X:127,516,504...127,584,529
Ensembl chr X:127,537,538...127,584,087
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
increases expression multiple interactions |
EXP ISO |
Cannabidiol results in increased expression of BDNF protein [Cannabidiol co-treated with moringin] results in increased expression of BDNF protein |
CTD |
PMID:19939866 PMID:30096889 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Becn1 |
beclin 1 |
multiple interactions increases expression |
ISO |
Cannabidiol inhibits the reaction [DMD gene mutant form results in decreased expression of BECN1 mRNA] Cannabidiol results in increased expression of BECN1 mRNA; Cannabidiol results in increased expression of BECN1 protein [PSEN1 protein affects the susceptibility to Cannabidiol] which results in increased expression of BECN1 protein; Chloroquine inhibits the reaction [Cannabidiol results in increased expression of BECN1 protein] |
CTD |
PMID:30074247 PMID:32060308 PMID:33096116 PMID:33244087 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bglap |
bone gamma-carboxyglutamate protein |
increases expression |
ISO |
Cannabidiol results in increased expression of BGLAP protein |
CTD |
PMID:32656944 |
|
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
|
|
G |
Bid |
BH3 interacting domain death agonist |
decreases expression |
ISO |
Cannabidiol results in decreased expression of BID mRNA |
CTD |
PMID:27932991 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in decreased expression of BIRC2 mRNA |
CTD |
PMID:30096889 |
|
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of BIRC5 mRNA |
CTD |
PMID:30096889 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Blm |
BLM RecQ like helicase |
decreases expression |
ISO |
Cannabidiol results in decreased expression of BLM mRNA |
CTD |
PMID:36519830 |
|
NCBI chr 1:134,409,832...134,496,073
Ensembl chr 1:134,409,857...134,484,312
|
|
G |
Bloc1s2 |
biogenesis of lysosomal organelles complex-1, subunit 2 |
increases expression |
ISO |
Cannabidiol results in increased expression of BLOC1S2 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 1:243,024,611...243,031,749
Ensembl chr 1:243,024,614...243,031,653
|
|
G |
Blvrb |
biliverdin reductase B |
increases expression |
ISO |
Cannabidiol results in increased expression of BLVRB mRNA |
CTD |
PMID:31518892 |
|
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
|
|
G |
Bmal1 |
basic helix-loop-helix ARNT like 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of BMAL1 mRNA |
CTD |
PMID:30307084 |
|
NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:167,331,633...167,430,231
|
|
G |
Bmp2 |
bone morphogenetic protein 2 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [TNF protein results in increased expression of BMP2 mRNA] |
CTD |
PMID:31250491 |
|
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
decreases expression increases expression |
ISO |
Cannabidiol results in decreased expression of BMP4 mRNA Cannabidiol results in increased expression of BMP4 mRNA |
CTD |
PMID:27918106 PMID:33244087 |
|
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
affects methylation |
EXP |
Cannabidiol affects the methylation of BMP6 gene |
CTD |
PMID:30521419 |
|
NCBI chr17:26,318,121...26,469,034
Ensembl chr17:26,318,569...26,470,365
|
|
G |
Bmp7 |
bone morphogenetic protein 7 |
affects methylation |
EXP |
Cannabidiol affects the methylation of BMP7 gene |
CTD |
PMID:30521419 |
|
NCBI chr 3:161,639,915...161,716,938
Ensembl chr 3:161,516,462...161,716,788
|
|
G |
Bnc2 |
basonuclin 2 |
increases expression |
ISO |
Cannabidiol results in increased expression of BNC2 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 5:98,679,071...99,079,742
Ensembl chr 5:98,687,410...99,079,426
|
|
G |
Bora |
bora, aurora kinase A activator |
increases expression |
ISO |
Cannabidiol results in increased expression of BORA mRNA |
CTD |
PMID:27918106 |
|
NCBI chr15:75,797,624...75,835,599
Ensembl chr15:75,797,891...75,821,322
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in decreased expression of BRAF mRNA; [Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of BRAF mRNA |
CTD |
PMID:30096889 PMID:32992648 |
|
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
decreases expression increases expression multiple interactions |
ISO |
Cannabidiol results in decreased expression of BRCA1 mRNA Cannabidiol results in increased expression of BRCA1 mRNA [Cannabidiol co-treated with moringin] results in increased expression of BRCA1 mRNA |
CTD |
PMID:27918106 PMID:30096889 PMID:33244087 PMID:36519830 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
multiple interactions decreases expression |
ISO |
[Oxygen co-treated with Ozone] inhibits the reaction [Cannabidiol results in decreased expression of BRCA2 mRNA]; Cannabidiol inhibits the reaction [[Oxygen co-treated with Ozone] results in increased expression of BRCA2 mRNA] |
CTD |
PMID:32992648 PMID:36519830 |
|
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
|
|
G |
Brcc3 |
BRCA1/BRCA2-containing complex subunit 3 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of BRCC3 mRNA |
CTD |
PMID:27932991 |
|
NCBI chr 9:1,986,942...1,989,484
Ensembl chr 9:1,986,575...1,991,080
|
|
G |
Brip1 |
BRCA1 interacting helicase 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of BRIP1 mRNA |
CTD |
PMID:36519830 |
|
NCBI chr10:70,907,266...71,031,502
Ensembl chr10:70,907,371...71,030,324
|
|
G |
Bsg |
basigin (Ok blood group) |
decreases expression multiple interactions |
ISO |
Cannabidiol results in decreased expression of BSG mRNA [Dronabinol co-treated with Cannabidiol] results in decreased expression of BSG mRNA; Cannabidiol promotes the reaction [Dronabinol results in decreased expression of BSG mRNA]; carfilzomib promotes the reaction [[Dronabinol co-treated with Cannabidiol] results in decreased expression of BSG mRNA]; Dronabinol promotes the reaction [Cannabidiol results in decreased expression of BSG mRNA] |
CTD |
PMID:27769052 |
|
NCBI chr 7:9,993,170...10,000,387
Ensembl chr 7:9,993,170...10,000,387
|
|
G |
Btd |
biotinidase |
increases expression |
ISO |
Cannabidiol results in increased expression of BTD mRNA |
CTD |
PMID:27918106 |
|
NCBI chr16:6,863,068...6,894,345
Ensembl chr16:6,862,407...6,940,945
|
|
G |
Btla |
B and T lymphocyte associated |
multiple interactions increases expression |
ISO |
Cannabidiol promotes the reaction [MOG protein modified form results in increased expression of BTLA mRNA] Cannabidiol results in increased expression of BTLA mRNA |
CTD |
PMID:27256343 |
|
NCBI chr11:55,563,683...55,588,187
Ensembl chr11:55,564,899...55,587,181
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
decreases expression |
ISO |
Cannabidiol results in decreased expression of BUB1 mRNA |
CTD |
PMID:36519830 |
|
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
decreases expression |
ISO |
Cannabidiol results in decreased expression of BUB1B mRNA |
CTD |
PMID:36519830 |
|
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
|
|
G |
C15h14orf119 |
similar to human chromosome 14 open reading frame 119 |
increases expression |
ISO |
Cannabidiol results in increased expression of C14ORF119 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr15:28,146,368...28,151,422
Ensembl chr15:28,146,333...28,155,180
|
|
G |
C1qa |
complement C1q A chain |
decreases expression |
ISO |
Cannabidiol results in decreased expression of C1QA mRNA |
CTD |
PMID:21542829 |
|
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
|
|
G |
C1qbp |
complement C1q binding protein |
increases expression |
ISO |
Cannabidiol results in increased expression of C1QBP mRNA |
CTD |
PMID:27714895 |
|
NCBI chr10:55,699,954...55,704,605
Ensembl chr10:55,699,954...55,704,649
|
|
G |
C1qc |
complement C1q C chain |
multiple interactions |
EXP |
Cannabidiol inhibits the reaction [Ketamine results in decreased expression of C1QC mRNA] |
CTD |
PMID:31823199 |
|
NCBI chr 5:149,127,424...149,130,732
Ensembl chr 5:149,127,415...149,131,017
|
|
G |
C2h5orf34 |
similar to human chromosome 5 open reading frame 34 |
increases expression |
ISO |
Cannabidiol results in increased expression of C5ORF34 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 2:51,553,223...51,577,090
Ensembl chr 2:51,555,432...51,577,085
|
|
G |
C5 |
complement C5 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [TNF protein results in decreased expression of C5 mRNA] |
CTD |
PMID:31250491 |
|
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
|
|
G |
C9h6orf141 |
similar to human chromosome 6 open reading frame 141 |
increases expression |
ISO |
Cannabidiol results in increased expression of C6ORF141 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 9:20,024,916...20,029,094
Ensembl chr 9:20,024,916...20,029,094
|
|
G |
Cabin1 |
calcineurin binding protein 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CABIN1 mRNA |
CTD |
PMID:27714895 |
|
NCBI chr20:12,893,314...13,015,357
Ensembl chr20:12,893,358...13,015,357
|
|
G |
Cabyr |
calcium binding tyrosine phosphorylation regulated |
increases expression |
ISO |
Cannabidiol results in increased expression of CABYR mRNA |
CTD |
PMID:27918106 |
|
NCBI chr18:3,892,062...3,904,391
Ensembl chr18:3,892,132...3,903,840
|
|
G |
Cacna1a |
calcium voltage-gated channel subunit alpha1 A |
affects methylation |
EXP |
Cannabidiol affects the methylation of CACNA1A gene |
CTD |
PMID:30521419 |
|
NCBI chr19:23,520,741...23,819,971
Ensembl chr19:23,520,741...23,823,225
|
|
G |
Cacna1g |
calcium voltage-gated channel subunit alpha1 G |
affects methylation |
EXP |
Cannabidiol affects the methylation of CACNA1G gene |
CTD |
PMID:30521419 |
|
NCBI chr10:79,354,998...79,422,960
Ensembl chr10:79,355,008...79,422,752
|
|
G |
Cacna1i |
calcium voltage-gated channel subunit alpha1 I |
affects methylation |
EXP |
Cannabidiol affects the methylation of CACNA1I gene |
CTD |
PMID:30521419 |
|
NCBI chr 7:111,835,996...111,947,418
Ensembl chr 7:111,836,012...111,944,688
|
|
G |
Cacna2d1 |
calcium voltage-gated channel auxiliary subunit alpha2delta 1 |
affects methylation |
EXP |
Cannabidiol affects the methylation of CACNA2D1 gene |
CTD |
PMID:30521419 |
|
NCBI chr 4:18,950,611...19,374,969
Ensembl chr 4:18,951,002...19,374,969
|
|
G |
Cacna2d2 |
calcium voltage-gated channel auxiliary subunit alpha2delta 2 |
affects methylation |
EXP |
Cannabidiol affects the methylation of CACNA2D2 gene |
CTD |
PMID:30521419 |
|
NCBI chr 8:108,072,208...108,203,516
Ensembl chr 8:108,072,454...108,203,173
|
|
G |
Cacybp |
calcyclin binding protein |
increases expression |
ISO |
Cannabidiol results in increased expression of CACYBP mRNA |
CTD |
PMID:27918106 |
|
NCBI chr13:72,437,485...72,447,810
Ensembl chr13:72,437,490...72,450,177
|
|
G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CAMK2A mRNA |
CTD |
PMID:28025562 |
|
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CAMK2B mRNA |
CTD |
PMID:28025562 PMID:33019509 |
|
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
|
|
G |
Camta1 |
calmodulin binding transcription activator 1 |
decreases methylation |
ISO |
Cannabidiol results in decreased methylation of CAMTA1 gene |
CTD |
PMID:33407853 |
|
NCBI chr 5:161,510,283...162,356,902
Ensembl chr 5:161,510,283...162,356,723
|
|
G |
Capn1 |
calpain 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CAPN1 mRNA |
CTD |
PMID:28025562 |
|
NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177
|
|
G |
Capn2 |
calpain 2 |
decreases expression multiple interactions |
ISO |
Cannabidiol results in decreased expression of CAPN2 mRNA [Cuprizone co-treated with Cannabidiol] results in decreased expression of CAPN2 protein |
CTD |
PMID:28025562 PMID:34122009 |
|
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
|
|
G |
Capn3 |
calpain 3 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CAPN3 mRNA |
CTD |
PMID:27932991 |
|
NCBI chr 3:107,407,518...107,457,858
Ensembl chr 3:107,407,850...107,457,858
|
|
G |
Car3 |
carbonic anhydrase 3 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CAR3 mRNA |
CTD |
PMID:31052254 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Cars1 |
cysteinyl-tRNA synthetase 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of CARS mRNA |
CTD |
PMID:21542829 |
|
NCBI chr 1:198,753,689...198,796,016
Ensembl chr 1:198,753,691...198,795,941
|
|
G |
Cask |
calcium/calmodulin dependent serine protein kinase |
decreases methylation |
ISO |
Cannabidiol results in decreased methylation of CASK gene |
CTD |
PMID:33407853 |
|
NCBI chr X:8,899,500...9,243,014
Ensembl chr X:8,899,833...9,238,694
|
|
G |
Casp1 |
caspase 1 |
multiple interactions decreases expression |
ISO |
2-chloro-5-nitrobenzanilide inhibits the reaction [Cannabidiol inhibits the reaction [Lipopolysaccharides results in increased activity of CASP1 protein]]; AM 251 inhibits the reaction [Cannabidiol inhibits the reaction [Lipopolysaccharides results in increased expression of CASP1 protein]]; Cannabidiol binds to and results in decreased activity of CASP1 protein; Cannabidiol inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP1 mRNA]; Cannabidiol inhibits the reaction [Lipopolysaccharides results in increased activity of CASP1 protein]; Cannabidiol inhibits the reaction [Lipopolysaccharides results in increased expression of CASP1 protein]; iodopravadoline inhibits the reaction [Cannabidiol results in decreased expression of CASP1 protein]; Rimonabant inhibits the reaction [Cannabidiol results in decreased expression of CASP1 protein] Cannabidiol results in decreased expression of CASP1 mRNA; Cannabidiol results in decreased expression of CASP1 protein |
CTD |
PMID:27932991 PMID:33955754 PMID:34269108 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp2 |
caspase 2 |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of CASP2 mRNA |
CTD |
PMID:30096889 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases cleavage increases expression |
ISO EXP |
[bafilomycin A1 co-treated with Cannabidiol] results in increased cleavage of CASP3 protein; [Cannabidiol co-treated with bafilomycin A1] results in increased cleavage of CASP3 protein; [Cannabidiol results in decreased expression of MIRLET7A1 mRNA] which results in increased expression of CASP3 mRNA; [Cannabidiol results in decreased expression of MIRLET7A1 mRNA] which results in increased expression of CASP3 protein; Acetylcysteine inhibits the reaction [Cannabidiol results in increased cleavage of CASP3 protein]; Chloroquine inhibits the reaction [Cannabidiol results in increased cleavage of CASP3 protein]; DIABLO protein affects the reaction [Cannabidiol results in increased cleavage of CASP3 protein]; tin protoporphyrin IX inhibits the reaction [[bafilomycin A1 co-treated with Cannabidiol] results in increased cleavage of CASP3 protein]; tin protoporphyrin IX inhibits the reaction [Cannabidiol results in increased cleavage of CASP3 protein] Cannabidiol inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP3 mRNA] Cannabidiol results in increased expression of CASP3 mRNA |
CTD |
PMID:27430346 PMID:30713602 PMID:31349651 PMID:31699976 PMID:32060308 PMID:32708634 PMID:32733202 PMID:32992648 PMID:33076330 PMID:33244087 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
increases expression decreases expression |
ISO |
Cannabidiol results in increased expression of CASP4 mRNA Cannabidiol results in decreased expression of CASP4 mRNA |
CTD |
PMID:21542829 PMID:27932991 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp6 |
caspase 6 |
decreases expression multiple interactions |
ISO |
Cannabidiol results in decreased expression of CASP6 mRNA [Cannabidiol co-treated with moringin] results in decreased expression of CASP6 mRNA |
CTD |
PMID:27932991 PMID:30096889 PMID:33019509 |
|
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
|
|
G |
Casp7 |
caspase 7 |
increases cleavage increases expression multiple interactions |
ISO |
Cannabidiol results in increased cleavage of CASP7 protein Cannabidiol results in increased expression of CASP7 mRNA; Cannabidiol results in increased expression of CASP7 protein [Cannabidiol co-treated with moringin] results in decreased expression of CASP7 mRNA |
CTD |
PMID:30096889 PMID:33244087 PMID:34575494 |
|
NCBI chr 1:255,437,195...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
decreases expression increases cleavage multiple interactions |
ISO |
Cannabidiol results in decreased expression of CASP8 mRNA Cannabidiol results in increased cleavage of CASP8 protein [Cannabidiol co-treated with moringin] results in decreased expression of CASP8 mRNA |
CTD |
PMID:27932991 PMID:30096889 PMID:31699976 PMID:31801206 PMID:33019509 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp8ap2 |
caspase 8 associated protein 2 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CASP8AP2 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 5:47,014,501...47,052,276
Ensembl chr 5:47,014,667...47,052,275
|
|
G |
Casp9 |
caspase 9 |
increases expression multiple interactions increases cleavage increases activity |
ISO |
Cannabidiol results in increased expression of CASP9 mRNA 3-methyladenine inhibits the reaction [Cannabidiol results in increased activity of CASP9 protein]; [Cannabidiol co-treated with moringin] results in decreased expression of CASP9 mRNA; Chloroquine inhibits the reaction [Cannabidiol results in increased cleavage of CASP9 protein] |
CTD |
PMID:30096889 PMID:31349651 PMID:31699976 PMID:32060308 PMID:33244087 PMID:34302491 More...
|
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
decreases activity multiple interactions increases expression |
ISO |
Cannabidiol results in decreased activity of CAT protein Cannabidiol inhibits the reaction [Haloperidol results in decreased activity of CAT protein] Cannabidiol results in increased expression of CAT protein |
CTD |
PMID:30217539 PMID:32752303 PMID:34774840 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cbfb |
core-binding factor subunit beta |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CBFB mRNA |
CTD |
PMID:27918106 |
|
NCBI chr19:33,049,162...33,092,752
Ensembl chr19:33,049,172...33,092,751
|
|
G |
Cbx8 |
chromobox 8 |
multiple interactions increases expression |
ISO |
Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of CBX8 mRNA] Cannabidiol results in increased expression of CBX8 mRNA |
CTD |
PMID:27918106 PMID:30825431 |
|
NCBI chr10:104,294,518...104,296,956
Ensembl chr10:104,294,518...104,297,024
|
|
G |
Ccar1 |
cell division cycle and apoptosis regulator 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of CCAR1 protein |
CTD |
PMID:34122009 |
|
NCBI chr20:30,685,916...30,728,531
Ensembl chr20:30,685,916...30,728,526
|
|
G |
Ccdc110 |
coiled-coil domain containing 110 |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of CCDC110 protein |
CTD |
PMID:34122009 |
|
NCBI chr16:46,315,745...46,337,050
Ensembl chr16:46,315,745...46,337,021
|
|
G |
Ccdc142 |
coiled-coil domain containing 142 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CCDC142 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 4:115,606,151...115,616,223
Ensembl chr 4:115,608,485...115,616,216
|
|
G |
Ccdc7b |
coiled-coil domain containing 7B |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CCDC7 mRNA |
CTD |
PMID:36519830 |
|
NCBI chr19:57,182,480...57,255,764
Ensembl chr19:57,182,509...57,255,763
|
|
G |
Ccdc8 |
coiled-coil domain containing 8 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CCDC8 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 1:77,679,521...77,682,849
Ensembl chr 1:77,679,218...77,683,090
|
|
G |
Ccl1 |
C-C motif chemokine ligand 1 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [TNF protein results in increased expression of CCL1 mRNA] [Plant Extracts results in increased abundance of Cannabidiol] which results in increased expression of CCL1 mRNA |
CTD |
PMID:31250491 PMID:32400224 |
|
NCBI chr10:67,128,331...67,131,109
Ensembl chr10:67,128,331...67,131,159
|
|
G |
Ccl17 |
C-C motif chemokine ligand 17 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [TNF protein results in increased expression of CCL17 mRNA] |
CTD |
PMID:31250491 |
|
NCBI chr19:10,202,317...10,203,768
Ensembl chr19:10,202,128...10,203,819
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression multiple interactions |
ISO |
Cannabidiol results in decreased expression of CCL2 mRNA Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of CCL2 mRNA]; Cannabidiol inhibits the reaction [Ethanol results in increased expression of CCL2 mRNA]; Cannabidiol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA] [Cannabidiol co-treated with Pam(3)CSK(4) peptide] results in increased secretion of CCL2 protein; Cannabidiol inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]; Cannabidiol promotes the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of CCL2 protein] |
CTD |
PMID:19910459 PMID:21542829 PMID:28935932 PMID:30033591 PMID:31250491 PMID:34740670 More...
|
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of CCL20 mRNA Cannabidiol inhibits the reaction [TNF protein results in increased expression of CCL20 mRNA] |
CTD |
PMID:31250491 PMID:33244087 PMID:36519830 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccl22 |
C-C motif chemokine ligand 22 |
multiple interactions |
ISO |
[lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in decreased expression of CCL22 mRNA Cannabidiol inhibits the reaction [TNF protein results in increased expression of CCL22 mRNA] |
CTD |
PMID:30742662 PMID:31250491 |
|
NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400
|
|
G |
Ccl26 |
C-C motif chemokine ligand 26 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [TNF protein results in decreased expression of CCL26 mRNA] |
CTD |
PMID:31250491 |
|
NCBI chr12:21,109,384...21,114,336
Ensembl chr12:21,109,421...21,114,335
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] |
CTD |
PMID:31250491 |
|
NCBI chr10:68,322,826...68,327,365
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
decreases expression multiple interactions |
ISO |
Cannabidiol results in decreased expression of CCL7 mRNA Cannabidiol inhibits the reaction [TNF protein results in increased expression of CCL7 mRNA] |
CTD |
PMID:21542829 PMID:31250491 |
|
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
|
|
G |
Ccl9 |
C-C motif chemokine ligand 9 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CCL6 mRNA |
CTD |
PMID:21542829 |
|
NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369
|
|
G |
Ccn2 |
cellular communication network factor 2 |
increases expression |
ISO |
Cannabidiol results in increased expression of CCN2 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccn4 |
cellular communication network factor 4 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [TNF protein results in increased expression of WISP1 mRNA] |
CTD |
PMID:31250491 |
|
NCBI chr 7:98,645,238...98,677,253
Ensembl chr 7:98,645,182...98,677,248
|
|
G |
Ccna2 |
cyclin A2 |
multiple interactions decreases expression |
ISO |
[Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of CCNA2 mRNA Cannabidiol results in decreased expression of CCNA2 mRNA |
CTD |
PMID:32992648 PMID:36519830 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions decreases expression |
ISO |
Cannabidiol promotes the reaction [[Oxygen co-treated with Ozone] results in decreased expression of CCNB1 mRNA] Cannabidiol results in decreased expression of CCNB1 mRNA |
CTD |
PMID:32992648 PMID:36519830 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnb2 |
cyclin B2 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CCNB2 mRNA |
CTD |
PMID:36519830 |
|
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression multiple interactions |
ISO |
Cannabidiol results in decreased expression of CCND1 mRNA; Cannabidiol results in decreased expression of CCND1 protein [lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in decreased expression of CCND1 mRNA [Cannabidiol co-treated with moringin] results in increased expression of CCND1 mRNA; Cannabidiol promotes the reaction [[Oxygen co-treated with Ozone] results in decreased expression of CCND1 mRNA] |
CTD |
PMID:21542829 PMID:30007266 PMID:30096889 PMID:30742662 PMID:32992648 PMID:34871667 More...
|
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd3 |
cyclin D3 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CCND3 mRNA; Cannabidiol results in decreased expression of CCND3 protein |
CTD |
PMID:34871667 PMID:36519830 |
|
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
|
|
G |
Ccndbp1 |
cyclin D1 binding protein 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CCNDBP1 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 3:107,962,402...107,974,234
Ensembl chr 3:107,962,261...107,974,233
|
|
G |
Ccne1 |
cyclin E1 |
decreases expression multiple interactions |
ISO |
Cannabidiol results in decreased expression of CCNE1 mRNA Cannabidiol results in decreased expression of CCNE1 mRNA; Cannabidiol results in decreased expression of CCNE1 protein [Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of CCNE1 mRNA |
CTD |
PMID:21542829 PMID:31349651 PMID:32992648 PMID:33244087 PMID:36519830 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccne2 |
cyclin E2 |
decreases expression multiple interactions |
ISO |
Cannabidiol results in decreased expression of CCNE2 mRNA [lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in decreased expression of CCNE2 mRNA |
CTD |
PMID:21542829 PMID:30742662 PMID:36519830 |
|
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
|
|
G |
Ccnf |
cyclin F |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CCNF mRNA |
CTD |
PMID:33244087 |
|
NCBI chr10:13,253,073...13,279,140
Ensembl chr10:13,253,380...13,279,101
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
multiple interactions |
ISO |
Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of CCR5 mRNA] |
CTD |
PMID:30825431 |
|
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
|
|
G |
Ccr6 |
C-C motif chemokine receptor 6 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [TNF protein results in decreased expression of CCR6 mRNA] |
CTD |
PMID:31250491 |
|
NCBI chr 1:52,474,477...52,508,301
Ensembl chr 1:52,474,168...52,498,603
|
|
G |
Cct4 |
chaperonin containing TCP1 subunit 4 |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of CCT4 protein |
CTD |
PMID:34122009 |
|
NCBI chr14:96,991,853...97,004,732
Ensembl chr14:96,991,859...97,005,267
|
|
G |
Cct6a |
chaperonin containing TCP1 subunit 6A |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of CCT6A protein [Cuprizone co-treated with Cannabidiol] results in decreased expression of CCT6A protein |
CTD |
PMID:34122009 |
|
NCBI chr12:26,872,736...26,883,125
Ensembl chr12:26,872,574...26,883,337
|
|
G |
Cct8 |
chaperonin containing TCP1 subunit 8 |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of CCT8 protein |
CTD |
PMID:34122009 |
|
NCBI chr11:26,710,370...26,722,079
Ensembl chr11:26,710,370...26,722,079
|
|
G |
Cd109 |
CD109 molecule |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CD109 mRNA |
CTD |
PMID:27932991 |
|
NCBI chr 8:79,454,480...79,569,195
Ensembl chr 8:79,454,480...79,569,194
|
|
G |
Cd14 |
CD14 molecule |
multiple interactions |
ISO |
[Plant Extracts results in increased abundance of Cannabidiol] which results in increased expression of CD14 mRNA |
CTD |
PMID:32400224 |
|
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cd151 |
CD151 molecule (Raph blood group) |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CD151 mRNA |
CTD |
PMID:27932991 |
|
NCBI chr 1:196,564,744...196,568,753
Ensembl chr 1:196,565,181...196,568,753
|
|
G |
Cd274 |
CD274 molecule |
increases expression |
ISO |
Cannabidiol results in increased expression of CD274 mRNA |
CTD |
PMID:21542829 |
|
NCBI chr 1:227,116,627...227,137,379
Ensembl chr 1:227,116,649...227,134,450
|
|
G |
Cd276 |
Cd276 molecule |
increases expression |
ISO |
Cannabidiol results in increased expression of CD276 mRNA |
CTD |
PMID:27932991 |
|
NCBI chr 8:58,937,751...58,968,082
Ensembl chr 8:58,937,751...58,968,380
|
|
G |
Cd33 |
CD33 molecule |
multiple interactions |
ISO |
Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of CD33 mRNA] |
CTD |
PMID:30825431 |
|
NCBI chr 1:93,935,418...93,940,452
Ensembl chr 1:93,930,971...93,950,149
|
|
G |
Cd34 |
CD34 molecule |
multiple interactions |
ISO |
Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of CD34 protein] |
CTD |
PMID:30825431 |
|
NCBI chr13:106,480,074...106,499,462
Ensembl chr13:106,480,043...106,499,832
|
|
G |
Cd40 |
CD40 molecule |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CD40 mRNA |
CTD |
PMID:27932991 |
|
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CD44 mRNA |
CTD |
PMID:27932991 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cd46 |
CD46 molecule |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CD46 mRNA |
CTD |
PMID:27932991 |
|
NCBI chr13:106,575,586...106,606,325
Ensembl chr13:106,574,858...106,660,445
|
|
G |
Cd47 |
Cd47 molecule |
increases expression |
ISO |
Cannabidiol results in increased expression of CD47 mRNA |
CTD |
PMID:27932991 |
|
NCBI chr11:50,906,052...50,970,000
Ensembl chr11:50,906,177...50,969,425
|
|
G |
Cd55 |
CD55 molecule (Cromer blood group) |
increases expression |
ISO |
Cannabidiol results in increased expression of CD55 mRNA |
CTD |
PMID:27932991 |
|
NCBI chr13:41,857,242...41,885,966
Ensembl chr13:41,857,395...41,885,831
|
|
G |
Cd59b |
CD59b molecule |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CD59 mRNA |
CTD |
PMID:27932991 |
|
NCBI chr 3:90,459,085...90,477,571
Ensembl chr 3:90,459,162...90,478,847
|
|
G |
Cd68 |
Cd68 molecule |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CD68 mRNA |
CTD |
PMID:27932991 |
|
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
|
|
G |
Cd69 |
Cd69 molecule |
multiple interactions |
ISO |
Cannabidiol promotes the reaction [MOG protein modified form results in increased expression of CD69 mRNA] |
CTD |
PMID:27256343 |
|
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542
|
|
G |
Cd81 |
Cd81 molecule |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CD81 mRNA |
CTD |
PMID:27932991 |
|
NCBI chr 1:198,235,861...198,251,660
Ensembl chr 1:198,241,484...198,251,660
|
|
G |
Cd82 |
Cd82 molecule |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CD82 mRNA |
CTD |
PMID:27932991 |
|
NCBI chr 3:79,387,361...79,431,847
Ensembl chr 3:79,385,887...79,431,809
|
|
G |
Cd99 |
CD99 molecule (Xg blood group) |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CD99 mRNA |
CTD |
PMID:27932991 |
|
NCBI chr20:54,418,239...54,422,882
|
|
G |
Cdc14b |
cell division cycle 14B |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CDC14B mRNA |
CTD |
PMID:31052254 |
|
NCBI chr17:844,731...934,787
Ensembl chr17:844,685...933,235
|
|
G |
Cdc20 |
cell division cycle 20 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CDC20 mRNA |
CTD |
PMID:36519830 |
|
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
|
|
G |
Cdc25a |
cell division cycle 25A |
decreases expression multiple interactions |
ISO |
Cannabidiol results in decreased expression of CDC25A mRNA [lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in decreased expression of CDC25A mRNA |
CTD |
PMID:21542829 PMID:30742662 PMID:36519830 |
|
NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701
|
|
G |
Cdc25b |
cell division cycle 25B |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CDC25B mRNA |
CTD |
PMID:36519830 |
|
NCBI chr 3:118,407,127...118,417,272
Ensembl chr 3:118,407,128...118,417,272
|
|
G |
Cdc25c |
cell division cycle 25C |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CDC25C mRNA |
CTD |
PMID:36519830 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdc37 |
cell division cycle 37, HSP90 cochaperone |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of CDC37 mRNA |
CTD |
PMID:30096889 |
|
NCBI chr 8:19,677,400...19,690,761
Ensembl chr 8:19,671,938...19,690,809
|
|
G |
Cdc45 |
cell division cycle 45 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CDC45 mRNA |
CTD |
PMID:36519830 |
|
NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619
|
|
G |
Cdc6 |
cell division cycle 6 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CDC6 mRNA |
CTD |
PMID:21542829 PMID:36519830 |
|
NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
|
|
G |
Cdca5 |
cell division cycle associated 5 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CDCA5 mRNA |
CTD |
PMID:36519830 |
|
NCBI chr 1:203,378,550...203,392,027
Ensembl chr 1:203,378,577...203,392,023
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [TNF protein results in increased expression of CDH1 mRNA] |
CTD |
PMID:31250491 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh2 |
cadherin 2 |
multiple interactions |
ISO |
[Dronabinol co-treated with Cannabidiol] inhibits the reaction [TGFB1 protein results in increased expression of CDH2 mRNA]; Cannabidiol inhibits the reaction [TGFB1 protein results in increased expression of CDH2 mRNA] |
CTD |
PMID:32049991 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
affects expression multiple interactions decreases expression |
ISO |
Cannabidiol affects the expression of CDK1 protein [Cannabidiol co-treated with moringin] results in increased expression of CDK1 mRNA; tanespimycin affects the reaction [Cannabidiol affects the expression of CDK1 protein]; VER 155008 affects the reaction [Cannabidiol affects the expression of CDK1 protein] Cannabidiol results in decreased expression of CDK1 mRNA |
CTD |
PMID:26504004 PMID:30096889 PMID:36519830 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
multiple interactions decreases expression |
ISO |
[Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of CDK2 mRNA Cannabidiol results in decreased expression of CDK2 mRNA; Cannabidiol results in decreased expression of CDK2 protein |
CTD |
PMID:31349651 PMID:32992648 PMID:34871667 PMID:36519830 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
multiple interactions decreases expression |
ISO |
[Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of CDK4 mRNA Cannabidiol results in decreased expression of CDK4 protein |
CTD |
PMID:32992648 PMID:34871667 |
|
NCBI chr 7:62,885,647...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdk5 |
cyclin-dependent kinase 5 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CDK5 mRNA |
CTD |
PMID:27918106 PMID:28025562 |
|
NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
|
|
G |
Cdk5r1 |
cyclin-dependent kinase 5 regulatory subunit 1 |
multiple interactions decreases expression |
ISO |
Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of CDK5R1 mRNA] Cannabidiol results in decreased expression of CDK5R1 mRNA |
CTD |
PMID:27256343 PMID:28025562 |
|
NCBI chr10:65,484,266...65,485,467
Ensembl chr10:65,483,941...65,488,456
|
|
G |
Cdk5rap1 |
CDK5 regulatory subunit associated protein 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CDK5RAP1 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 3:142,838,081...142,872,669
Ensembl chr 3:142,708,028...142,872,677
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CDK6 protein |
CTD |
PMID:34871667 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression multiple interactions decreases expression |
ISO |
Cannabidiol results in increased expression of CDKN1A mRNA [lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in increased expression of CDKN1A mRNA Cannabidiol results in increased expression of CDKN1A mRNA; Cannabidiol results in increased expression of CDKN1A protein [Cannabidiol co-treated with moringin] results in decreased expression of CDKN1A mRNA Cannabidiol results in decreased expression of CDKN1A mRNA |
CTD |
PMID:21542829 PMID:27918106 PMID:30096889 PMID:30742662 PMID:31052254 PMID:31349651 PMID:36519830 More...
|
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
increases expression decreases expression multiple interactions |
ISO EXP |
Cannabidiol results in increased expression of CDKN2A mRNA Cannabidiol results in decreased expression of CDKN2A mRNA Cannabidiol promotes the reaction [[Oxygen co-treated with Ozone] results in increased expression of CDKN2A mRNA] Cannabidiol results in increased expression of CDKN2A mRNA; Cannabidiol results in increased expression of CDKN2A protein |
CTD |
PMID:21542829 PMID:32553926 PMID:32992648 PMID:36519830 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B |
increases expression |
ISO |
Cannabidiol results in increased expression of CDKN2B mRNA |
CTD |
PMID:21542829 PMID:36519830 |
|
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
|
|
G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CDKN2C mRNA |
CTD |
PMID:33244087 PMID:36519830 |
|
NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278
|
|
G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CDKN3 mRNA |
CTD |
PMID:36519830 |
|
NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
|
|
G |
Cdr1 |
cerebellar degeneration related 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of CDR1 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr X:139,590,816...139,594,141
|
|
G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CDT1 mRNA |
CTD |
PMID:33244087 PMID:36519830 |
|
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
|
|
G |
Cdv3 |
carnitine deficiency-associated gene expressed in ventricle 3 |
increases expression |
ISO |
Cannabidiol results in increased expression of CDV3 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 8:103,934,006...103,947,173
Ensembl chr 8:103,933,996...103,947,192
|
|
G |
Cdyl |
chromodomain Y-like |
increases expression |
ISO |
Cannabidiol results in increased expression of CDYL mRNA |
CTD |
PMID:27918106 |
|
NCBI chr17:28,982,009...29,204,345
Ensembl chr17:28,982,037...29,204,313
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
multiple interactions increases expression |
ISO |
[lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in increased expression of CEBPB mRNA Cannabidiol results in increased expression of CEBPB mRNA |
CTD |
PMID:30742662 PMID:33244087 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cend1 |
cell cycle exit and neuronal differentiation 1 |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of CEND1 protein |
CTD |
PMID:34122009 |
|
NCBI chr 1:196,525,153...196,528,152
Ensembl chr 1:196,523,920...196,528,302
|
|
G |
Cenpe |
centromere protein E |
multiple interactions |
ISO |
Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of CENPE mRNA] |
CTD |
PMID:30825431 |
|
NCBI chr 2:223,637,035...223,695,692
Ensembl chr 2:223,636,998...223,695,669
|
|
G |
Cenph |
centromere protein H |
increases expression |
ISO |
Cannabidiol results in increased expression of CENPH mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 2:31,894,253...31,910,182
Ensembl chr 2:31,894,667...31,910,154
|
|
G |
Cep20 |
centrosomal protein 20 |
increases expression |
ISO |
Cannabidiol results in increased expression of FOPNL mRNA |
CTD |
PMID:27918106 |
|
NCBI chr10:714,051...736,826
Ensembl chr10:714,151...736,837
|
|
G |
Cep290 |
centrosomal protein 290 |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of CEP290 protein |
CTD |
PMID:34122009 |
|
NCBI chr 7:35,310,071...35,399,392
Ensembl chr 7:35,310,199...35,399,392
|
|
G |
Cep78 |
centrosomal protein 78 |
increases expression |
ISO |
Cannabidiol results in increased expression of CEP78 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 1:213,246,183...213,275,275
Ensembl chr 1:213,246,187...213,275,181
|
|
G |
Ces1d |
carboxylesterase 1D |
increases expression |
ISO |
Cannabidiol results in increased expression of CES1 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Cfap300 |
cilia and flagella associated protein 300 |
increases expression |
ISO |
Cannabidiol results in increased expression of CFAP300 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 8:5,180,180...5,198,840
Ensembl chr 8:5,180,675...5,198,807
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of CFLAR mRNA [Cannabidiol co-treated with moringin] results in decreased expression of CFLAR mRNA; [PSEN1 protein affects the susceptibility to Cannabidiol] which affects the expression of CFLAR mRNA |
CTD |
PMID:30096889 PMID:30742662 PMID:33096116 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Chac1 |
ChaC glutathione-specific gamma-glutamylcyclotransferase 1 |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of CHAC1 mRNA [Dronabinol co-treated with Cannabidiol] results in increased expression of CHAC1 mRNA |
CTD |
PMID:21542829 PMID:26504004 PMID:27918106 |
|
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
|
|
G |
Chd2 |
chromodomain helicase DNA binding protein 2 |
increases expression |
ISO |
Cannabidiol results in increased expression of CHD2 mRNA |
CTD |
PMID:21542829 |
|
NCBI chr 1:127,188,146...127,317,041
Ensembl chr 1:127,190,059...127,300,502
|
|
G |
Chek1 |
checkpoint kinase 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CHEK1 mRNA |
CTD |
PMID:36519830 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Chek2 |
checkpoint kinase 2 |
multiple interactions decreases expression |
ISO |
[Cannabidiol co-treated with moringin] results in decreased expression of CHEK2 mRNA Cannabidiol results in decreased expression of CHEK2 mRNA |
CTD |
PMID:30096889 PMID:36519830 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
increases expression |
ISO |
Cannabidiol results in increased expression of CHRM2 mRNA; Cannabidiol results in increased expression of CHRM2 protein |
CTD |
PMID:27918106 |
|
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
|
|
G |
Chrna2 |
cholinergic receptor nicotinic alpha 2 subunit |
decreases expression multiple interactions |
ISO |
Cannabidiol results in decreased expression of CHRNA2 mRNA [lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in decreased expression of CHRNA2 mRNA |
CTD |
PMID:30742662 |
|
NCBI chr15:40,342,317...40,358,601
Ensembl chr15:40,342,317...40,358,601
|
|
G |
Chrna7 |
cholinergic receptor nicotinic alpha 7 subunit |
decreases activity |
ISO |
Cannabidiol results in decreased activity of CHRNA7 protein |
CTD |
PMID:24140434 |
|
NCBI chr 1:116,715,286...116,837,223
Ensembl chr 1:116,714,711...116,837,240
|
|
G |
Chst10 |
carbohydrate sulfotransferase 10 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CHST10 mRNA |
CTD |
PMID:21542829 |
|
NCBI chr 9:41,092,805...41,122,737
Ensembl chr 9:41,092,808...41,122,503
|
|
G |
Chst14 |
carbohydrate sulfotransferase 14 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CHST14 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 3:105,916,481...105,918,538
Ensembl chr 3:105,916,466...105,918,548
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
multiple interactions decreases expression |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of CHUK mRNA Cannabidiol results in decreased expression of CHUK mRNA |
CTD |
PMID:30096889 PMID:31801206 |
|
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
|
|
G |
Cirbp |
cold inducible RNA binding protein |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of CIRBP protein |
CTD |
PMID:34122009 |
|
NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818
|
|
G |
Cish |
cytokine inducible SH2-containing protein |
increases expression |
ISO |
Cannabidiol results in increased expression of CISH mRNA |
CTD |
PMID:30742662 |
|
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
|
|
G |
Cldn1 |
claudin 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of CLDN1 protein |
CTD |
PMID:32656944 |
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Cldn4 |
claudin 4 |
increases expression |
ISO |
Cannabidiol results in increased expression of CLDN4 protein |
CTD |
PMID:32656944 |
|
NCBI chr12:21,751,638...21,753,436
Ensembl chr12:21,751,331...21,753,436
|
|
G |
Clec4e |
C-type lectin domain family 4, member E |
increases expression |
ISO |
Cannabidiol results in increased expression of CLEC4E mRNA |
CTD |
PMID:21542829 |
|
NCBI chr 4:156,606,927...156,612,911
Ensembl chr 4:156,607,614...156,612,767
|
|
G |
Clic1 |
chloride intracellular channel 1 |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of CLIC1 protein |
CTD |
PMID:34122009 |
|
NCBI chr20:3,764,867...3,773,711
Ensembl chr20:3,761,461...3,773,712
|
|
G |
Clip1 |
CAP-GLY domain containing linker protein 1 |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in decreased expression of CLIP1 mRNA |
CTD |
PMID:30096889 |
|
NCBI chr12:32,910,932...33,017,891
Ensembl chr12:32,910,977...33,017,884
|
|
G |
Clip3 |
CAP-GLY domain containing linker protein 3 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CLIP3 mRNA |
CTD |
PMID:31801206 |
|
NCBI chr 1:85,547,170...85,563,187
Ensembl chr 1:85,547,206...85,563,184
|
|
G |
Clock |
clock circadian regulator |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CLOCK mRNA |
CTD |
PMID:30307084 PMID:33019509 |
|
NCBI chr14:31,908,542...31,992,673
Ensembl chr14:31,908,566...31,990,400
|
|
G |
Cmklr2 |
chemerin chemokine-like receptor 2 |
increases expression |
ISO |
Cannabidiol results in increased expression of CMKLR2 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 9:64,583,310...64,618,127
Ensembl chr 9:64,585,594...64,586,655
|
|
G |
Cmpk2 |
cytidine/uridine monophosphate kinase 2 |
multiple interactions decreases expression |
ISO |
Cannabidiol promotes the reaction [MOG protein modified form results in increased expression of CMPK2 mRNA] Cannabidiol results in decreased expression of CMPK2 mRNA; Cannabidiol results in decreased expression of CMPK2 protein 2-chloro-5-nitrobenzanilide inhibits the reaction [Cannabidiol inhibits the reaction [Lipopolysaccharides results in increased expression of CMPK2 protein]]; Cannabidiol inhibits the reaction [Lipopolysaccharides promotes the reaction [PPARG protein binds to CMPK2 promoter]]; Cannabidiol inhibits the reaction [Lipopolysaccharides promotes the reaction [PPARG protein results in increased expression of CMPK2 mRNA]]; Cannabidiol inhibits the reaction [Lipopolysaccharides results in increased expression of CMPK2 protein] |
CTD |
PMID:27256343 PMID:34269108 |
|
NCBI chr 6:43,073,706...43,085,183
Ensembl chr 6:43,073,796...43,085,183
|
|
G |
Cnih2 |
cornichon family AMPA receptor auxiliary protein 2 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CNIH2 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 1:202,399,416...202,405,110
Ensembl chr 1:202,399,419...202,405,089
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of CNP protein |
CTD |
PMID:34122009 |
|
NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
multiple interactions affects response to substance decreases expression increases expression |
ISO EXP |
AM 251 inhibits the reaction [Cannabidiol results in increased expression of CNR1 protein]; Cannabidiol analog binds to and results in decreased activity of CNR1 protein; Cannabidiol analog inhibits the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to CNR1 protein]; CNR1 polymorphism affects the susceptibility to [Dronabinol co-treated with Cannabidiol]; CNR1 protein promotes the reaction [Cannabidiol results in decreased secretion of SERPINE1 protein] CNR1 protein affects the susceptibility to Cannabidiol [1,3-dimethoxy-5-methyl-2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)benzene co-treated with CNR1 protein] affects the susceptibility to Cannabidiol; Cannabidiol inhibits the reaction [[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol co-treated with 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol deficiency] results in increased expression of CNR1 mRNA] Cannabidiol inhibits the reaction [Methylazoxymethanol Acetate results in decreased methylation of CNR1 promoter]; Cannabidiol inhibits the reaction [Methylazoxymethanol Acetate results in increased expression of CNR1 mRNA]; Cannabidiol inhibits the reaction [Methylazoxymethanol Acetate results in increased expression of CNR1 protein]; Cannabidiol inhibits the reaction [Poly I-C inhibits the reaction [Rimonabant binds to CNR1 protein]] Cannabidiol results in decreased expression of CNR1 protein |
CTD |
PMID:20668920 PMID:27932991 PMID:29624642 PMID:30033591 PMID:30496751 PMID:30550613 PMID:31013550 PMID:31202911 PMID:33817834 More...
|
|
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
|
|
G |
Cnr2 |
cannabinoid receptor 2 |
multiple interactions affects expression |
ISO |
Cannabidiol analog binds to and results in increased activity of CNR2 protein; Cannabidiol analog inhibits the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to CNR2 protein]; CNR2 protein promotes the reaction [Cannabidiol results in decreased secretion of SERPINE1 protein] Cannabidiol affects the expression of CNR2 mRNA Cannabidiol inhibits the reaction [[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol co-treated with 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol deficiency] results in decreased expression of CNR2 mRNA] |
CTD |
PMID:20668920 PMID:29624642 PMID:30033591 PMID:32733202 |
|
NCBI chr 5:148,125,222...148,151,548
Ensembl chr 5:148,125,604...148,151,548
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
increases expression |
ISO |
Cannabidiol results in increased expression of COL1A1 mRNA; Cannabidiol results in increased expression of COL1A1 protein |
CTD |
PMID:32656944 PMID:33872753 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
multiple interactions |
ISO |
Cannabidiol analog inhibits the reaction [TGFB1 protein results in increased expression of COL1A2 mRNA] |
CTD |
PMID:30033591 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of COL3A1 mRNA Cannabidiol inhibits the reaction [TNF protein results in increased expression of COL3A1 mRNA] |
CTD |
PMID:31250491 PMID:33872753 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of COL4A1 mRNA Cannabidiol inhibits the reaction [TNF protein results in increased expression of COL4A1 mRNA] |
CTD |
PMID:21542829 PMID:31250491 |
|
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
|
|
G |
Col5a2 |
collagen type V alpha 2 chain |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in increased expression of COL5A2 protein |
CTD |
PMID:34122009 |
|
NCBI chr 9:47,448,736...47,598,396
Ensembl chr 9:47,448,736...47,598,154
|
|
G |
Cox6a2 |
cytochrome c oxidase subunit 6A2 |
increases expression |
ISO |
Cannabidiol results in increased expression of COX6A2 mRNA |
CTD |
PMID:21542829 |
|
NCBI chr 1:182,788,528...182,790,746
Ensembl chr 1:182,788,528...182,789,274
|
|
G |
Cpd |
carboxypeptidase D |
multiple interactions |
ISO |
[lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in decreased expression of CPD mRNA |
CTD |
PMID:30742662 |
|
NCBI chr10:61,623,528...61,687,491
Ensembl chr10:61,623,526...61,687,491
|
|
G |
Cpeb1 |
cytoplasmic polyadenylation element binding protein 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of CPEB1 mRNA |
CTD |
PMID:21542829 |
|
NCBI chr 1:135,300,048...135,407,688
Ensembl chr 1:135,300,461...135,409,760
|
|
G |
Cpsf1 |
cleavage and polyadenylation specific factor 1 |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of CPSF1 protein |
CTD |
PMID:34122009 |
|
NCBI chr 7:108,319,429...108,330,023
Ensembl chr 7:108,319,434...108,329,934
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [Ethanol results in decreased expression of CPT1A mRNA] |
CTD |
PMID:28935932 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Cradd |
CASP2 and RIPK1 domain containing adaptor with death domain |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of CRADD mRNA |
CTD |
PMID:30096889 |
|
NCBI chr 7:29,940,240...29,952,907
Ensembl chr 7:29,798,586...29,952,907
|
|
G |
Crb1 |
crumbs cell polarity complex component 1 |
affects methylation |
EXP |
Cannabidiol affects the methylation of CRB1 gene |
CTD |
PMID:30521419 |
|
NCBI chr13:50,801,484...50,989,261
Ensembl chr13:50,800,959...50,989,261
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
increases phosphorylation multiple interactions decreases expression |
ISO |
Cannabidiol results in increased phosphorylation of CREB1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Cannabidiol results in increased phosphorylation of CREB1 protein]; SB 203580 inhibits the reaction [Cannabidiol results in increased phosphorylation of CREB1 protein] Cannabidiol results in decreased expression of CREB1 mRNA |
CTD |
PMID:28601556 PMID:33019509 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Creb3 |
cAMP responsive element binding protein 3 |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of CREB3 mRNA |
CTD |
PMID:30096889 |
|
NCBI chr 5:57,817,835...57,823,171
Ensembl chr 5:57,817,832...57,824,390
|
|
G |
Crem |
cAMP responsive element modulator |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of CREM mRNA] |
CTD |
PMID:27256343 |
|
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
|
|
G |
Crh |
corticotropin releasing hormone |
multiple interactions |
ISO |
[Cannabidiol co-treated with Sertraline] results in decreased expression of CRH mRNA |
CTD |
PMID:34262461 |
|
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
|
|
G |
Crot |
carnitine O-octanoyltransferase |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CROT mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 4:25,068,270...25,133,111
Ensembl chr 4:25,080,587...25,133,109
|
|
G |
Crtc2 |
CREB regulated transcription coactivator 2 |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of CRTC2 mRNA |
CTD |
PMID:30096889 |
|
NCBI chr 2:175,709,603...175,719,768
Ensembl chr 2:175,709,644...175,719,763
|
|
G |
Cry2 |
cryptochrome circadian regulator 2 |
increases expression |
ISO |
Cannabidiol results in increased expression of CRY2 mRNA |
CTD |
PMID:30307084 |
|
NCBI chr 3:78,374,995...78,405,001
Ensembl chr 3:78,374,995...78,404,965
|
|
G |
Cryl1 |
crystallin, lambda 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CRYL1 mRNA |
CTD |
PMID:31052254 |
|
NCBI chr15:31,427,011...31,545,997
Ensembl chr15:31,427,054...31,545,997
|
|
G |
Cryz |
crystallin zeta |
increases expression |
ISO |
Cannabidiol results in increased expression of CRYZ protein |
CTD |
PMID:34122009 |
|
NCBI chr 2:243,552,037...243,580,369
Ensembl chr 2:243,552,119...243,579,758
|
|
G |
Csad |
cysteine sulfinic acid decarboxylase |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CSAD mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 7:133,308,571...133,337,914
Ensembl chr 7:133,308,574...133,337,615
|
|
G |
Csf1 |
colony stimulating factor 1 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [TNF protein results in increased expression of CSF1 mRNA] |
CTD |
PMID:31250491 |
|
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
|
|
G |
Csf2 |
colony stimulating factor 2 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [TNF protein results in increased expression of CSF2 mRNA] |
CTD |
PMID:31250491 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Csf2ra |
colony stimulating factor 2 receptor subunit alpha |
affects methylation |
EXP |
Cannabidiol affects the methylation of CSF2RA gene |
CTD |
PMID:30521419 |
|
NCBI chr14:98,089...103,261
Ensembl chr14:89,172...103,128
|
|
G |
Csf3 |
colony stimulating factor 3 |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of CSF3 mRNA Cannabidiol inhibits the reaction [TNF protein results in increased expression of CSF3 mRNA] |
CTD |
PMID:31250491 PMID:33244087 PMID:36519830 |
|
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Csk |
C-terminal Src kinase |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of CSK mRNA |
CTD |
PMID:30096889 |
|
NCBI chr 8:58,029,748...58,048,742
Ensembl chr 8:58,029,749...58,048,292
|
|
G |
Csnk1e |
casein kinase 1, epsilon |
affects methylation |
EXP |
Cannabidiol affects the methylation of CSNK1E gene |
CTD |
PMID:30521419 |
|
NCBI chr 7:110,983,322...111,006,926
Ensembl chr 7:110,983,318...111,006,794
|
|
G |
Csrnp1 |
cysteine and serine rich nuclear protein 1 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of CSRNP1 mRNA] |
CTD |
PMID:27256343 |
|
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
|
|
G |
Cstf1 |
cleavage stimulation factor subunit 1 |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of CSTF1 protein |
CTD |
PMID:34122009 |
|
NCBI chr 3:161,144,533...161,156,294
Ensembl chr 3:161,144,548...161,156,300
|
|
G |
Cth |
cystathionine gamma-lyase |
multiple interactions increases expression |
ISO |
[Dronabinol co-treated with Cannabidiol] results in increased expression of CTH mRNA Cannabidiol results in increased expression of CTH mRNA |
CTD |
PMID:26504004 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Ctnnb1 |
catenin beta 1 |
decreases phosphorylation multiple interactions |
ISO |
Cannabidiol results in decreased phosphorylation of CTNNB1 protein [Cannabidiol co-treated with SB 203580] results in decreased phosphorylation of CTNNB1 protein; Cannabidiol promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of CTNNB1 protein] |
CTD |
PMID:32060308 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctnnd1 |
catenin delta 1 |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in increased expression of CTNND1 protein |
CTD |
PMID:34122009 |
|
NCBI chr 3:69,683,328...69,734,550
Ensembl chr 3:69,683,313...69,734,516
|
|
G |
Ctr9 |
CTR9 homolog, Paf1/RNA polymerase II complex component |
increases expression |
ISO |
Cannabidiol results in increased expression of CTR9 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 1:165,137,277...165,167,303
Ensembl chr 1:165,137,215...165,167,303
|
|
G |
Ctsb |
cathepsin B |
decreases expression increases expression |
ISO |
Cannabidiol results in decreased expression of CTSB mRNA Cannabidiol results in increased expression of CTSB mRNA |
CTD |
PMID:27714895 PMID:27932991 PMID:36519830 |
|
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Ctsd |
cathepsin D |
multiple interactions |
ISO |
[PSEN1 protein affects the susceptibility to Cannabidiol] which affects the expression of CTSD mRNA |
CTD |
PMID:33096116 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Ctsg |
cathepsin G |
increases expression |
ISO |
Cannabidiol results in increased expression of CTSG mRNA |
CTD |
PMID:21542829 |
|
NCBI chr15:29,930,988...29,937,353
Ensembl chr15:29,931,003...29,937,353
|
|
G |
Cul4b |
cullin 4B |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of CUL4B protein |
CTD |
PMID:34122009 |
|
NCBI chr X:117,287,481...117,326,688
Ensembl chr X:117,287,484...117,326,688
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [TNF protein results in increased expression of CX3CL1 mRNA] Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of CX3CL1 protein] |
CTD |
PMID:30825431 PMID:31250491 |
|
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CX3CR1 mRNA |
CTD |
PMID:21542829 |
|
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of CXCL1 mRNA Cannabidiol inhibits the reaction [TNF protein results in increased expression of CXCL1 mRNA] |
CTD |
PMID:31250491 PMID:33244087 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
multiple interactions |
ISO |
[Dronabinol co-treated with Cannabidiol] inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA]; [Dronabinol co-treated with Cannabidiol] inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 protein]; [Dronabinol co-treated with Cannabidiol] inhibits the reaction [Poly I-C results in increased expression of CXCL10 protein]; Cannabidiol inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA]; Cannabidiol inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 protein]; Cannabidiol inhibits the reaction [Lipopolysaccharides results in increased secretion of CXCL10 protein]; Cannabidiol inhibits the reaction [Poly I-C results in increased expression of CXCL10 mRNA]; Cannabidiol inhibits the reaction [Poly I-C results in increased expression of CXCL10 protein]; Cannabidiol inhibits the reaction [Poly I-C results in increased secretion of CXCL10 protein]; Cannabidiol inhibits the reaction [TNF protein results in increased expression of CXCL10 mRNA] |
CTD |
PMID:31250491 PMID:32244040 PMID:34740670 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl11 |
C-X-C motif chemokine ligand 11 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [TNF protein results in increased expression of CXCL11 mRNA] |
CTD |
PMID:31250491 |
|
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CXCL12 mRNA |
CTD |
PMID:31052254 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl14 |
C-X-C motif chemokine ligand 14 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CXCL14 mRNA |
CTD |
PMID:21542829 |
|
NCBI chr17:8,317,933...8,325,956
Ensembl chr17:8,317,933...8,324,839
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of CXCL2 mRNA Cannabidiol inhibits the reaction [TNF protein results in increased expression of CXCL2 mRNA] [Plant Extracts results in increased abundance of Cannabidiol] which results in increased expression of CXCL2 mRNA; Cannabidiol inhibits the reaction [Ethanol results in increased expression of CXCL2 mRNA] |
CTD |
PMID:28935932 PMID:31250491 PMID:32400224 PMID:33244087 PMID:36519830 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of CXCL1 mRNA [Plant Extracts results in increased abundance of Cannabidiol] which results in increased expression of CXCL1 mRNA Cannabidiol inhibits the reaction [TNF protein results in increased expression of CXCL1 mRNA] |
CTD |
PMID:31250491 PMID:32400224 PMID:33244087 |
|
NCBI chr14:17,270,146...17,289,458
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of CXCL9 mRNA] Cannabidiol inhibits the reaction [TNF protein results in increased expression of CXCL9 mRNA] |
CTD |
PMID:27256343 PMID:31250491 |
|
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
|
|
G |
Cxcr1 |
C-X-C motif chemokine receptor 1 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of CXCR1 mRNA] |
CTD |
PMID:27256343 |
|
NCBI chr 9:75,768,124...75,771,122
Ensembl chr 9:75,766,770...75,771,084
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
multiple interactions increases expression |
ISO |
[lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in increased expression of CXCR4 mRNA Cannabidiol results in increased expression of CXCR4 mRNA [Dronabinol co-treated with Cannabidiol] results in decreased expression of CXCR4 mRNA; carfilzomib promotes the reaction [[Dronabinol co-treated with Cannabidiol] results in decreased expression of CXCR4 mRNA] |
CTD |
PMID:27769052 PMID:30742662 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cyb5r3 |
cytochrome b5 reductase 3 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CYB5R3 protein |
CTD |
PMID:34122009 |
|
NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298
|
|
G |
Cybb |
cytochrome b-245 beta chain |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [Ethanol results in increased expression of CYBB mRNA] |
CTD |
PMID:28935932 |
|
NCBI chr X:13,360,583...13,392,517
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cyc1 |
cytochrome c-1 |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of CYC1 mRNA |
CTD |
PMID:30096889 |
|
NCBI chr 7:108,067,106...108,069,483
Ensembl chr 7:108,067,115...108,069,479
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions increases expression decreases expression |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of CYCS mRNA Cannabidiol results in increased expression of CYCS protein Cannabidiol results in decreased expression of CYCS mRNA |
CTD |
PMID:27932991 PMID:30096889 PMID:31349651 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054
|
|
G |
Cyld |
CYLD lysine 63 deubiquitinase |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of CYLD mRNA [Cannabidiol co-treated with moringin] results in increased expression of CYLD mRNA |
CTD |
PMID:30096889 PMID:31801206 |
|
NCBI chr19:18,310,632...18,373,696
Ensembl chr19:18,314,019...18,373,658
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
decreases activity multiple interactions |
ISO |
Cannabidiol results in decreased activity of CYP19A1 protein Cannabidiol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of CYP19A1 mRNA] |
CTD |
PMID:31953017 |
|
NCBI chr 8:54,553,165...54,580,758
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases activity increases expression multiple interactions |
ISO |
Cannabidiol results in decreased activity of CYP1A1 protein Cannabidiol results in increased expression of CYP1A1 mRNA AHR protein affects the reaction [Cannabidiol results in increased expression of CYP1A1 mRNA]; herbimycin inhibits the reaction [Cannabidiol results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:24667653 PMID:26187180 PMID:31052254 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity multiple interactions increases expression |
ISO |
Cannabidiol results in decreased activity of CYP1A2 protein [Plant Extracts results in increased abundance of Cannabidiol] which results in increased expression of CYP1A2 mRNA Cannabidiol results in increased expression of CYP1A2 mRNA |
CTD |
PMID:24667653 PMID:31052254 PMID:33096940 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
decreases activity multiple interactions increases expression |
ISO |
Cannabidiol results in decreased activity of CYP2B10 [Plant Extracts results in increased abundance of Cannabidiol] which results in increased expression of CYP2B10 mRNA Cannabidiol results in increased expression of CYP2B10 mRNA |
CTD |
PMID:8043019 PMID:31052254 PMID:33096940 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
decreases activity |
ISO |
Cannabidiol results in decreased activity of CYP2B6 protein |
CTD |
PMID:24667653 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c66 |
cytochrome P450, family 2, subfamily c, polypeptide 66 |
multiple interactions |
ISO |
[Plant Extracts results in increased abundance of Cannabidiol] which results in increased expression of CYP2C66 mRNA |
CTD |
PMID:33096940 |
|
NCBI chr 1:237,078,517...237,169,841
Ensembl chr 1:237,078,517...237,169,650
|
|
G |
Cyp2c6v1 |
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
decreases activity |
ISO |
Cannabidiol results in decreased activity of CYP2C19 protein |
CTD |
PMID:24667653 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
multiple interactions |
ISO |
[Plant Extracts results in increased abundance of Cannabidiol] which results in increased expression of CYP2C29 mRNA |
CTD |
PMID:33096940 |
|
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
decreases activity |
ISO |
Cannabidiol results in decreased activity of CYP2D6 protein |
CTD |
PMID:21821735 PMID:24667653 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of CYP2E1 mRNA |
CTD |
PMID:31052254 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
multiple interactions increases metabolic processing |
ISO |
Cannabidiol inhibits the reaction [CYP2J2 protein results in increased metabolism of anandamide] CYP2J2 protein results in increased metabolism of Cannabidiol |
CTD |
PMID:29689453 |
|
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases activity |
ISO |
Cannabidiol results in decreased activity of CYP3A4 protein |
CTD |
PMID:24667653 |
|
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
decreases activity |
ISO |
Cannabidiol results in decreased activity of CYP3A5 protein |
CTD |
PMID:24667653 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyrib |
CYFIP related Rac1 interactor B |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CYRIB mRNA |
CTD |
PMID:21542829 |
|
NCBI chr 7:95,633,876...95,760,588
Ensembl chr 7:95,633,876...95,697,686
|
|
G |
Cyth4 |
cytohesin 4 |
multiple interactions |
EXP |
Cannabidiol inhibits the reaction [Ketamine results in decreased expression of CYTH4 mRNA] |
CTD |
PMID:31823199 |
|
NCBI chr 7:110,152,232...110,176,741
Ensembl chr 7:110,152,272...110,176,741
|
|
G |
Cytip |
cytohesin 1 interacting protein |
decreases expression |
ISO |
Cannabidiol results in decreased expression of CYTIP mRNA |
CTD |
PMID:21542829 |
|
NCBI chr 3:42,698,058...42,774,955
Ensembl chr 3:42,698,768...42,725,993
|
|
G |
Daglb |
diacylglycerol lipase, beta |
decreases expression |
ISO |
Cannabidiol results in decreased expression of DAGLB mRNA |
CTD |
PMID:27918106 |
|
NCBI chr12:11,059,732...11,102,170
Ensembl chr12:11,059,732...11,102,154
|
|
G |
Dapk3 |
death-associated protein kinase 3 |
affects methylation |
EXP |
Cannabidiol affects the methylation of DAPK3 gene |
CTD |
PMID:30521419 |
|
NCBI chr 7:8,524,182...8,532,552
Ensembl chr 7:8,524,183...8,532,558
|
|
G |
Dbf4 |
DBF4 zinc finger |
decreases expression |
ISO |
Cannabidiol results in decreased expression of DBF4 mRNA |
CTD |
PMID:36519830 |
|
NCBI chr 4:25,676,570...25,701,152
Ensembl chr 4:25,676,634...25,701,066
|
|
G |
Dclre1b |
DNA cross-link repair 1B |
decreases expression |
ISO |
Cannabidiol results in decreased expression of DCLRE1B mRNA |
CTD |
PMID:36519830 |
|
NCBI chr 2:191,309,909...191,318,399
Ensembl chr 2:191,309,913...191,318,423
|
|
G |
Dct |
dopachrome tautomerase |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of DCT mRNA; Cannabidiol results in increased expression of DCT protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Cannabidiol results in increased expression of DCT mRNA]; SB 203580 inhibits the reaction [Cannabidiol results in increased expression of DCT mRNA] |
CTD |
PMID:28601556 |
|
NCBI chr15:95,062,006...95,100,863
Ensembl chr15:95,062,003...95,100,836
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of DDIT3 mRNA [Bilirubin co-treated with Rotenone] promotes the reaction [Cannabidiol results in increased expression of DDIT3 mRNA]; Bilirubin inhibits the reaction [Cannabidiol results in increased expression of DDIT3 mRNA]; Rotenone promotes the reaction [Cannabidiol results in increased expression of DDIT3 mRNA] [Dronabinol co-treated with Cannabidiol] results in increased expression of DDIT3 mRNA; DDIT3 protein affects the reaction [Cannabidiol results in increased cleavage of PARP1 protein]; DDIT3 protein affects the reaction [Cannabidiol results in increased expression of DIABLO protein] Cannabidiol results in increased expression of DDIT3 mRNA; Cannabidiol results in increased expression of DDIT3 protein |
CTD |
PMID:21542829 PMID:26504004 PMID:29441458 PMID:31699976 PMID:32033040 PMID:33244087 More...
|
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of DDIT4 mRNA [lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in increased expression of DDIT4 mRNA [Cannabidiol co-treated with moringin] results in decreased expression of DDIT4 mRNA; [Dronabinol co-treated with Cannabidiol] results in increased expression of DDIT4 mRNA |
CTD |
PMID:21542829 PMID:26504004 PMID:30096889 PMID:30742662 PMID:33244087 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of DDR1 mRNA |
CTD |
PMID:27256343 |
|
NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
|
|
G |
Ddt |
D-dopachrome tautomerase |
decreases expression |
ISO |
Cannabidiol results in decreased expression of DDT mRNA |
CTD |
PMID:27932991 |
|
NCBI chr20:12,884,216...12,886,687
Ensembl chr20:12,884,243...12,888,482
|
|
G |
Ddx18 |
DEAD-box helicase 18 |
increases expression |
ISO |
Cannabidiol results in increased expression of DDX18 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr13:32,729,697...32,743,161
Ensembl chr13:32,729,700...32,743,161
|
|
G |
Ddx39a |
DExD-box helicase 39A |
increases expression |
ISO |
Cannabidiol results in increased expression of DDX39 mRNA |
CTD |
PMID:31052254 |
|
NCBI chr19:24,418,743...24,427,422
Ensembl chr19:24,418,114...24,426,954
|
|
G |
Ddx46 |
DEAD-box helicase 46 |
increases expression |
ISO |
Cannabidiol results in increased expression of DDX46 protein |
CTD |
PMID:34122009 |
|
NCBI chr17:8,944,197...8,988,476
Ensembl chr17:8,944,454...8,988,439
|
|
G |
Depdc7 |
DEP domain containing 7 |
increases expression |
ISO |
Cannabidiol results in increased expression of DEPDC7 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 3:91,099,111...91,121,152
Ensembl chr 3:91,099,835...91,121,124
|
|
G |
Deptor |
DEP domain containing MTOR-interacting protein |
multiple interactions |
ISO |
[PSEN1 protein affects the susceptibility to Cannabidiol] which affects the expression of DEPTOR mRNA |
CTD |
PMID:33096116 |
|
NCBI chr 7:86,514,859...86,668,817
Ensembl chr 7:86,514,988...86,667,773
|
|
G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of DGAT1 mRNA] |
CTD |
PMID:27256343 |
|
NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299
|
|
G |
Dgcr8 |
DGCR8 microprocessor complex subunit |
decreases expression |
ISO |
Cannabidiol results in decreased expression of DGCR8 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr11:82,704,673...82,737,251
Ensembl chr11:82,704,729...82,737,242
|
|
G |
Dhx8 |
DEAH-box helicase 8 |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of DHX8 protein |
CTD |
PMID:34122009 |
|
NCBI chr10:86,667,641...86,705,454
Ensembl chr10:86,667,834...86,705,137
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
increases expression decreases expression affects localization multiple interactions |
ISO |
Cannabidiol results in increased expression of DIABLO protein Cannabidiol results in decreased expression of DIABLO mRNA Cannabidiol affects the localization of DIABLO protein [Cannabidiol co-treated with moringin] results in decreased expression of DIABLO mRNA; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cannabidiol promotes the reaction [DIABLO protein binds to XIAP protein]]; Cannabidiol promotes the reaction [DIABLO protein binds to XIAP protein]; DDIT3 protein affects the reaction [Cannabidiol results in increased expression of DIABLO protein]; DIABLO protein affects the reaction [Cannabidiol results in decreased expression of XIAP protein]; DIABLO protein affects the reaction [Cannabidiol results in increased cleavage of CASP3 protein]; DIABLO protein affects the reaction [Cannabidiol results in increased cleavage of PARP1 protein] |
CTD |
PMID:27714895 PMID:30096889 PMID:31699976 |
|
NCBI chr12:33,055,784...33,070,400
Ensembl chr12:33,055,263...33,070,387
|
|
G |
Dido1 |
death inducer-obliterator 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of DIDO1 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 3:167,772,535...167,825,894
Ensembl chr 3:167,772,770...167,817,218
|
|
G |
Dio2 |
iodothyronine deiodinase 2 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of DIO2 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:109,665,523...109,679,809
|
|
G |
Dis3 |
DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of DIS3 protein |
CTD |
PMID:34122009 |
|
NCBI chr15:75,820,040...75,850,450
Ensembl chr15:75,823,436...75,850,642
|
|
G |
Dld |
dihydrolipoamide dehydrogenase |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of DLD protein |
CTD |
PMID:34122009 |
|
NCBI chr 6:47,904,153...47,924,814
Ensembl chr 6:47,903,914...47,924,795
|
|
G |
Dlg2 |
discs large MAGUK scaffold protein 2 |
increases expression |
ISO |
Cannabidiol results in increased expression of DLG2 protein |
CTD |
PMID:34122009 |
|
NCBI chr 1:144,451,653...146,503,949
Ensembl chr 1:144,451,472...146,499,475
|
|
G |
Dlg4 |
discs large MAGUK scaffold protein 4 |
affects methylation multiple interactions |
EXP ISO |
Cannabidiol affects the methylation of DLG4 gene [Dronabinol co-treated with Cannabidiol] results in decreased susceptibility to [[APP gene mutant form co-treated with PSEN1 gene mutant form] results in increased expression of DLG4 protein] Cannabidiol inhibits the reaction [amyloid beta-protein (1-42) results in decreased expression of DLG4 protein] |
CTD |
PMID:27567873 PMID:30521419 PMID:33817834 |
|
NCBI chr10:54,740,700...54,769,097
Ensembl chr10:54,739,470...54,767,153
|
|
G |
Dlgap1 |
DLG associated protein 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of DLGAP1 mRNA |
CTD |
PMID:33019509 |
|
NCBI chr 9:109,857,500...110,726,817
Ensembl chr 9:110,167,448...110,726,817
|
|
G |
Dll1 |
delta like canonical Notch ligand 1 |
multiple interactions increases expression |
ISO |
Cannabidiol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of DLL1 mRNA] Cannabidiol results in increased expression of DLL1 mRNA |
CTD |
PMID:30742662 |
|
NCBI chr 1:56,312,062...56,320,177
Ensembl chr 1:56,312,066...56,320,179
|
|
G |
Dll4 |
delta like canonical Notch ligand 4 |
multiple interactions |
ISO |
Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of DLL4 protein] |
CTD |
PMID:30825431 |
|
NCBI chr 3:106,317,114...106,327,004
Ensembl chr 3:106,316,986...106,326,931
|
|
G |
Dlst |
dihydrolipoamide S-succinyltransferase |
decreases expression |
ISO |
Cannabidiol results in decreased expression of DLST protein |
CTD |
PMID:34122009 |
|
NCBI chr 6:104,758,511...104,783,296
Ensembl chr 6:104,758,631...104,783,296
|
|
G |
Dlx5 |
distal-less homeobox 5 |
increases expression |
ISO |
Cannabidiol results in increased expression of DLX5 protein |
CTD |
PMID:32656944 |
|
NCBI chr 4:34,999,139...35,003,504
Ensembl chr 4:34,999,139...35,003,407
|
|
G |
Dmd |
dystrophin |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [DMD gene mutant form results in decreased expression of ATG12 mRNA]; Cannabidiol inhibits the reaction [DMD gene mutant form results in decreased expression of ATG4B mRNA]; Cannabidiol inhibits the reaction [DMD gene mutant form results in decreased expression of BECN1 mRNA]; Cannabidiol inhibits the reaction [DMD gene mutant form results in decreased expression of ULK1 mRNA]; Cannabidiol inhibits the reaction [DMD gene mutant form results in increased expression of IL6 protein]; Cannabidiol inhibits the reaction [DMD gene mutant form results in increased expression of IL6RA mRNA]; Cannabidiol inhibits the reaction [DMD gene mutant form results in increased expression of NOS2 mRNA]; Cannabidiol inhibits the reaction [DMD gene mutant form results in increased expression of TGFB1 mRNA]; Cannabidiol inhibits the reaction [DMD gene mutant form results in increased expression of TNF mRNA]; Cannabidiol inhibits the reaction [DMD gene mutant form results in increased expression of TNF protein] |
CTD |
PMID:30074247 |
|
NCBI chr X:47,272,324...49,504,219
Ensembl chr X:47,272,331...49,504,207
|
|
G |
Dmp1 |
dentin matrix acidic phosphoprotein 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of DMP1 mRNA |
CTD |
PMID:33872753 |
|
NCBI chr14:5,528,441...5,542,078
Ensembl chr14:5,528,431...5,539,323
|
|
G |
Dnajb1 |
DnaJ heat shock protein family (Hsp40) member B1 |
increases expression |
ISO |
Cannabidiol results in increased expression of DNAJB1 mRNA |
CTD |
PMID:26504004 PMID:31518892 |
|
NCBI chr19:24,522,717...24,526,458
Ensembl chr19:24,522,717...24,526,458
|
|
G |
Dnajb11 |
DnaJ heat shock protein family (Hsp40) member B11 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of DNAJB11 mRNA |
CTD |
PMID:31052254 |
|
NCBI chr11:78,151,750...78,168,259
Ensembl chr11:78,150,429...78,180,407
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
multiple interactions increases expression |
ISO |
[Dronabinol co-treated with Cannabidiol] results in increased expression of DNAJB4 mRNA Cannabidiol results in increased expression of DNAJB4 mRNA |
CTD |
PMID:26504004 |
|
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
multiple interactions increases expression |
ISO |
[Dronabinol co-treated with Cannabidiol] results in increased expression of DNAJB9 mRNA Cannabidiol results in increased expression of DNAJB9 mRNA |
CTD |
PMID:26504004 |
|
NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
|
|
G |
Dner |
delta/notch-like EGF repeat containing |
increases expression |
ISO |
Cannabidiol results in increased expression of DNER mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 9:85,586,985...85,902,820
Ensembl chr 9:85,586,987...85,902,637
|
|
G |
Dnm2 |
dynamin 2 |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in increased expression of DNM2 protein |
CTD |
PMID:34122009 |
|
NCBI chr 8:19,978,313...20,060,162
Ensembl chr 8:19,978,400...20,060,157
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
decreases methylation |
ISO |
Cannabidiol results in decreased methylation of DNMT3A gene |
CTD |
PMID:32579259 |
|
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
|
|
G |
Dnmt3l |
DNA methyltransferase 3 like |
increases expression |
ISO |
Cannabidiol results in increased expression of DNMT3L mRNA |
CTD |
PMID:21542829 |
|
NCBI chr20:10,614,933...10,629,516
Ensembl chr20:10,614,934...10,629,516
|
|
G |
Dok2 |
docking protein 2 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of DOK2 mRNA |
CTD |
PMID:21542829 |
|
NCBI chr15:45,826,984...45,841,409
Ensembl chr15:45,827,398...45,841,402
|
|
G |
Drd2 |
dopamine receptor D2 |
decreases expression decreases methylation multiple interactions |
ISO EXP |
Cannabidiol results in decreased expression of DRD2 mRNA Cannabidiol results in decreased methylation of DRD2 gene Cannabidiol inhibits the reaction [Dronabinol results in decreased methylation of DRD2 gene]; Cannabidiol inhibits the reaction [Dronabinol results in increased expression of DRD2 mRNA] |
CTD |
PMID:33019509 PMID:33285233 |
|
NCBI chr 8:49,708,903...49,772,888
Ensembl chr 8:49,708,927...49,772,875
|
|
G |
Drd3 |
dopamine receptor D3 |
multiple interactions |
EXP |
Cannabidiol inhibits the reaction [Methylazoxymethanol Acetate results in increased expression of DRD3 mRNA] |
CTD |
PMID:32360362 |
|
NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596
|
|
G |
Dscaml1 |
DS cell adhesion molecule-like 1 |
increases methylation |
ISO |
Cannabidiol results in increased methylation of DSCAML1 gene |
CTD |
PMID:32579259 |
|
NCBI chr 8:45,740,298...46,057,322
Ensembl chr 8:45,740,298...46,057,320
|
|
G |
Dscc1 |
DNA replication and sister chromatid cohesion 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of DSCC1 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 7:86,482,588...86,498,212
Ensembl chr 7:86,482,588...86,498,212
|
|
G |
Dspp |
dentin sialophosphoprotein |
increases expression |
ISO |
Cannabidiol results in increased expression of DSPP mRNA |
CTD |
PMID:33872753 |
|
NCBI chr14:5,565,562...5,571,669
Ensembl chr14:5,565,629...5,571,672
|
|
G |
Dstn |
destrin, actin depolymerizing factor |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of DSTN protein |
CTD |
PMID:34122009 |
|
NCBI chr 3:131,284,647...131,311,361
Ensembl chr 3:131,284,648...131,311,379
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of DUSP1 mRNA |
CTD |
PMID:21542829 PMID:33244087 |
|
NCBI chr10:16,680,489...16,683,276
|
|
G |
Dusp4 |
dual specificity phosphatase 4 |
increases expression |
ISO |
Cannabidiol results in increased expression of DUSP4 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr16:57,376,659...57,398,161
Ensembl chr16:57,377,229...57,398,138
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
increases expression |
ISO |
Cannabidiol results in increased expression of DUSP5 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
multiple interactions increases expression |
ISO |
[Cannabidiol co-treated with MOG protein modified form] results in increased expression of DUSP6 mRNA; Cannabidiol promotes the reaction [MOG protein modified form results in increased expression of DUSP6 mRNA] Cannabidiol results in increased expression of DUSP6 mRNA |
CTD |
PMID:27256343 PMID:33244087 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Dyrk1a |
dual specificity tyrosine phosphorylation regulated kinase 1A |
decreases expression |
ISO |
Cannabidiol results in decreased expression of DYRK1A mRNA |
CTD |
PMID:28025562 |
|
NCBI chr11:33,890,706...34,009,420
Ensembl chr11:33,890,490...34,009,420
|
|
G |
E2f1 |
E2F transcription factor 1 |
multiple interactions decreases expression increases expression |
ISO |
[Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of E2F1 mRNA Cannabidiol results in decreased expression of E2F1 mRNA Cannabidiol results in increased expression of E2F1 mRNA |
CTD |
PMID:27714895 PMID:27918106 PMID:32992648 PMID:33244087 PMID:36519830 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E2f2 |
E2F transcription factor 2 |
increases expression decreases expression |
ISO |
Cannabidiol results in increased expression of E2F2 mRNA Cannabidiol results in decreased expression of E2F2 mRNA |
CTD |
PMID:30742662 PMID:33244087 PMID:36519830 |
|
NCBI chr 5:148,399,193...148,422,595
Ensembl chr 5:148,399,642...148,421,217
|
|
G |
E2f5 |
E2F transcription factor 5 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of E2F5 mRNA |
CTD |
PMID:30742662 |
|
NCBI chr 2:86,997,331...87,012,901
Ensembl chr 2:86,997,332...87,012,990
|
|
G |
E2f7 |
E2F transcription factor 7 |
increases expression |
ISO |
Cannabidiol results in increased expression of E2F7 mRNA |
CTD |
PMID:36519830 |
|
NCBI chr 7:46,150,533...46,192,739
Ensembl chr 7:46,151,293...46,192,734
|
|
G |
Ece1 |
endothelin converting enzyme 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of ECE1 mRNA |
CTD |
PMID:28025562 |
|
NCBI chr 5:150,077,679...150,179,375
Ensembl chr 5:150,077,644...150,179,371
|
|
G |
Ect2 |
epithelial cell transforming 2 |
increases expression |
ISO |
Cannabidiol results in increased expression of ECT2 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 2:109,975,813...110,037,911
Ensembl chr 2:109,975,813...110,037,911
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [TNF protein results in increased expression of EGF mRNA] |
CTD |
PMID:31250491 |
|
NCBI chr 2:218,219,408...218,302,370
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
ISO |
[Dronabinol co-treated with Cannabidiol] results in decreased expression of EGFR mRNA; [Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of EGFR mRNA; Cannabidiol inhibits the reaction [TNF protein results in increased expression of EGFR mRNA]; Pertussis Toxin inhibits the reaction [[Dronabinol co-treated with Cannabidiol] results in decreased expression of EGFR mRNA] |
CTD |
PMID:31250491 PMID:32049991 PMID:32992648 |
|
NCBI chr14:91,176,931...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egr1 |
early growth response 1 |
increases expression multiple interactions decreases expression |
ISO EXP |
Cannabidiol results in increased expression of EGR1 mRNA [Dronabinol co-treated with Cannabidiol] results in increased expression of EGR1 mRNA Cannabidiol results in decreased expression of EGR1 protein |
CTD |
PMID:26504004 PMID:28344069 |
|
NCBI chr18:26,463,333...26,465,531
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Eid2 |
EP300 interacting inhibitor of differentiation 2 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of EID2 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 1:83,538,217...83,542,262
|
|
G |
Eif1 |
eukaryotic translation initiation factor 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of EIF1 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr10:85,246,751...85,248,842
Ensembl chr10:85,246,764...85,427,327
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
decreases expression increases phosphorylation |
ISO |
Cannabidiol results in decreased expression of EIF2AK3 mRNA Cannabidiol results in increased phosphorylation of EIF2AK3 protein |
CTD |
PMID:31699976 PMID:33019509 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif3a |
eukaryotic translation initiation factor 3, subunit A |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in increased expression of EIF3A protein |
CTD |
PMID:34122009 |
|
NCBI chr 1:259,902,767...259,932,976
Ensembl chr 1:259,902,680...259,932,976
|
|
G |
Eif3b |
eukaryotic translation initiation factor 3, subunit B |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of EIF3B protein |
CTD |
PMID:34122009 |
|
NCBI chr12:14,196,403...14,220,865
Ensembl chr12:14,196,403...14,220,886
|
|
G |
Eif4b |
eukaryotic translation initiation factor 4B |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in decreased expression of EIF4B mRNA |
CTD |
PMID:30096889 |
|
NCBI chr 7:133,206,637...133,228,436
|
|
G |
Eif4e |
eukaryotic translation initiation factor 4E |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of EIF4E mRNA |
CTD |
PMID:30096889 |
|
NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of EIF4EBP1 mRNA [Cannabidiol co-treated with moringin] results in increased expression of EIF4EBP1 mRNA |
CTD |
PMID:21542829 PMID:30096889 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Eif5a |
eukaryotic translation initiation factor 5A |
decreases expression |
ISO |
Cannabidiol results in decreased expression of EIF5A mRNA |
CTD |
PMID:21542829 |
|
NCBI chr10:54,640,104...54,644,845
Ensembl chr10:54,640,024...54,644,656
|
|
G |
Elf3 |
E74 like ETS transcription factor 3 |
increases expression |
ISO |
Cannabidiol results in increased expression of ELF3 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr13:46,690,460...46,695,394
Ensembl chr13:46,690,466...46,695,481
|
|
G |
Elk1 |
ETS transcription factor ELK1 |
decreases expression multiple interactions |
ISO |
Cannabidiol results in decreased expression of ELK1 mRNA [Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of ELK1 mRNA |
CTD |
PMID:32992648 |
|
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
|
|
G |
Ell2 |
elongation factor for RNA polymerase II 2 |
increases expression |
ISO |
Cannabidiol results in increased expression of ELL2 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 2:5,189,375...5,258,781
Ensembl chr 2:5,189,971...5,258,781
|
|
G |
Emc9 |
ER membrane protein complex subunit 9 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of EMC9 mRNA |
CTD |
PMID:31052254 |
|
NCBI chr15:29,071,881...29,076,098
Ensembl chr15:29,071,883...29,076,098
|
|
G |
Emcn |
endomucin |
multiple interactions |
ISO |
Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of EMCN mRNA] |
CTD |
PMID:30825431 |
|
NCBI chr 2:225,891,100...225,970,932
Ensembl chr 2:225,891,100...225,970,929
|
|
G |
Eme1 |
essential meiotic structure-specific endonuclease 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of EME1 mRNA |
CTD |
PMID:36519830 |
|
NCBI chr10:79,586,736...79,595,515
Ensembl chr10:79,586,729...79,595,435
|
|
G |
Endod1 |
endonuclease domain containing 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of ENDOD1 protein |
CTD |
PMID:34122009 |
|
NCBI chr 8:11,209,123...11,238,680
Ensembl chr 8:11,211,110...11,238,892
|
|
G |
Eng |
endoglin |
multiple interactions |
ISO |
Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of ENG protein] |
CTD |
PMID:30825431 |
|
NCBI chr 3:15,934,566...15,972,618
Ensembl chr 3:15,934,518...15,973,230
|
|
G |
Eno2 |
enolase 2 |
multiple interactions |
EXP |
Cannabidiol inhibits the reaction [3-nitropropionic acid results in decreased expression of ENO2 mRNA] |
CTD |
PMID:17672854 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Eny2 |
ENY2, transcription and export complex 2 subunit |
decreases expression |
ISO |
Cannabidiol results in decreased expression of ENY2 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 7:75,581,215...75,605,903
Ensembl chr 7:75,581,240...75,605,897
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
decreases methylation |
ISO |
Cannabidiol results in decreased methylation of EPAS1 gene |
CTD |
PMID:33407853 |
|
NCBI chr 6:7,790,236...7,871,246
Ensembl chr 6:7,790,647...7,871,228
|
|
G |
Epb41l3 |
erythrocyte membrane protein band 4.1-like 3 |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of EPB41L3 protein |
CTD |
PMID:34122009 |
|
NCBI chr 9:109,056,178...109,260,607
Ensembl chr 9:109,016,113...109,260,607
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of EPHX1 mRNA |
CTD |
PMID:27256343 |
|
NCBI chr13:92,714,315...92,744,124
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Epn3 |
epsin 3 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of EPN3 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr10:79,438,978...79,449,516
Ensembl chr10:79,438,978...79,447,356
|
|
G |
Erap1 |
endoplasmic reticulum aminopeptidase 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of ERAP1 protein |
CTD |
PMID:34122009 |
|
NCBI chr 2:3,931,817...3,970,735
Ensembl chr 2:3,931,904...3,972,447
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
multiple interactions decreases expression |
ISO |
[Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of ERBB2 mRNA; [Oxygen co-treated with Ozone] inhibits the reaction [Cannabidiol results in decreased expression of ERBB2 mRNA]; Cannabidiol inhibits the reaction [[Oxygen co-treated with Ozone] results in decreased expression of ERBB2 mRNA] |
CTD |
PMID:32992648 |
|
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Ercc6 |
ERCC excision repair 6, chromatin remodeling factor |
decreases expression |
ISO |
Cannabidiol results in decreased expression of ERCC6 mRNA |
CTD |
PMID:36519830 |
|
NCBI chr16:7,764,983...7,835,587
Ensembl chr16:7,765,013...7,835,587
|
|
G |
Ereg |
epiregulin |
increases expression |
ISO |
Cannabidiol results in increased expression of EREG mRNA |
CTD |
PMID:36519830 |
|
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
|
|
G |
Erh |
ERH, mRNA splicing and mitosis factor |
increases expression |
ISO |
Cannabidiol results in increased expression of ERH protein |
CTD |
PMID:34122009 |
|
NCBI chr 6:100,280,930...100,291,449
Ensembl chr 6:100,280,930...100,291,210
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
decreases expression increases phosphorylation |
ISO |
Cannabidiol results in decreased expression of ERN1 mRNA Cannabidiol results in increased phosphorylation of ERN1 protein |
CTD |
PMID:31699976 PMID:33019509 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of ERRFI1 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 5:161,323,981...161,337,289
Ensembl chr 5:161,323,998...161,337,282
|
|
G |
Espl1 |
extra spindle pole bodies like 1, separase |
multiple interactions |
ISO |
Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of ESPL1 mRNA] |
CTD |
PMID:30825431 |
|
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
|
|
G |
Ets2 |
ETS proto-oncogene 2, transcription factor |
increases expression |
ISO |
Cannabidiol results in increased expression of ETS2 mRNA |
CTD |
PMID:27256343 |
|
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
|
|
G |
Exo1 |
exonuclease 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of EXO1 mRNA |
CTD |
PMID:36519830 |
|
NCBI chr13:87,809,725...87,834,654
Ensembl chr13:87,809,810...87,834,654
|
|
G |
Exosc4 |
exosome component 4 |
increases expression |
ISO |
Cannabidiol results in increased expression of EXOSC4 protein |
CTD |
PMID:34122009 |
|
NCBI chr 7:108,047,831...108,050,573
Ensembl chr 7:108,047,831...108,050,573
|
|
G |
Ezr |
ezrin |
affects methylation decreases expression |
EXP ISO |
Cannabidiol affects the methylation of EZR gene Cannabidiol results in decreased expression of EZR protein |
CTD |
PMID:30521419 PMID:34122009 |
|
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
|
|
G |
F3 |
coagulation factor III, tissue factor |
increases expression |
ISO |
Cannabidiol results in increased expression of F3 protein |
CTD |
PMID:27556861 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Faah |
fatty acid amide hydrolase |
decreases expression |
ISO |
Cannabidiol results in decreased expression of FAAH protein |
CTD |
PMID:33817834 |
|
NCBI chr 5:129,479,774...129,499,018
Ensembl chr 5:129,479,824...129,498,677
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
multiple interactions decreases expression |
ISO |
Cannabidiol inhibits the reaction [11-(dansylamino)undecanoic acid binds to FABP1 protein] Cannabidiol results in decreased expression of FABP1 mRNA |
CTD |
PMID:31052254 PMID:31110286 |
|
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
|
|
G |
Fadd |
Fas associated via death domain |
decreases expression |
ISO |
Cannabidiol results in decreased expression of FADD mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fads1 |
fatty acid desaturase 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of FADS1 mRNA |
CTD |
PMID:31052254 |
|
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
|
|
G |
Fam174c |
family with sequence similarity 174 member C |
increases expression |
ISO |
Cannabidiol results in increased expression of FAM174C mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 7:9,531,995...9,533,705
|
|
G |
Fam217b |
family with sequence similarity 217, member B |
decreases expression |
ISO |
Cannabidiol results in decreased expression of FAM217B mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 3:165,505,574...165,515,273
Ensembl chr 3:165,501,532...165,513,377
|
|
G |
Fanca |
FA complementation group A |
decreases expression |
ISO |
Cannabidiol results in decreased expression of FANCA mRNA |
CTD |
PMID:36519830 |
|
NCBI chr19:51,304,021...51,362,586
Ensembl chr19:51,304,021...51,362,527
|
|
G |
Fancb |
FA complementation group B |
decreases expression |
ISO |
Cannabidiol results in decreased expression of FANCB mRNA |
CTD |
PMID:36519830 |
|
NCBI chr X:29,403,771...29,420,484
Ensembl chr X:29,403,771...29,420,192
|
|
G |
Fancc |
FA complementation group C |
decreases expression |
ISO |
Cannabidiol results in decreased expression of FANCC mRNA |
CTD |
PMID:36519830 |
|
NCBI chr17:1,680,660...1,822,610
Ensembl chr17:1,681,324...1,829,376
|
|
G |
Fancd2 |
FA complementation group D2 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of FANCD2 mRNA |
CTD |
PMID:36519830 |
|
NCBI chr 4:146,679,014...146,743,422
Ensembl chr 4:146,679,179...146,743,412
|
|
G |
Fancg |
FA complementation group G |
decreases expression |
ISO |
Cannabidiol results in decreased expression of FANCG mRNA |
CTD |
PMID:36519830 |
|
NCBI chr 5:57,230,287...57,240,067
Ensembl chr 5:57,231,685...57,240,029
|
|
G |
Fanci |
FA complementation group I |
decreases expression |
ISO |
Cannabidiol results in decreased expression of FANCI mRNA |
CTD |
PMID:36519830 |
|
NCBI chr 1:133,327,264...133,383,661
Ensembl chr 1:133,327,297...133,383,640
|
|
G |
Fancm |
FA complementation group M |
decreases expression |
ISO |
Cannabidiol results in decreased expression of FANCM mRNA |
CTD |
PMID:36519830 |
|
NCBI chr 6:83,126,903...83,180,455
Ensembl chr 6:83,127,093...83,180,028
|
|
G |
Far1 |
fatty acyl CoA reductase 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of FAR1 protein |
CTD |
PMID:34122009 |
|
NCBI chr 1:167,644,622...167,705,868
Ensembl chr 1:167,644,677...167,705,730
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of FAS mRNA [Plant Extracts results in increased abundance of Cannabidiol] which results in increased expression of FAS mRNA [Cannabidiol co-treated with moringin] results in decreased expression of FAS mRNA |
CTD |
PMID:30096889 PMID:30742662 PMID:32400224 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
multiple interactions |
ISO |
[Plant Extracts results in increased abundance of Cannabidiol] which results in increased expression of FASL mRNA |
CTD |
PMID:32400224 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fasn |
fatty acid synthase |
multiple interactions decreases expression |
ISO |
Cannabidiol inhibits the reaction [Ethanol results in increased expression of FASN mRNA]; Cannabidiol inhibits the reaction [Ethanol results in increased expression of FASN protein] Cannabidiol results in decreased expression of FASN mRNA |
CTD |
PMID:28935932 PMID:31052254 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fbxo32 |
F-box protein 32 |
multiple interactions increases expression |
ISO |
[Dronabinol co-treated with Cannabidiol] results in increased expression of FBXO32 mRNA Cannabidiol results in increased expression of FBXO32 mRNA |
CTD |
PMID:26504004 |
|
NCBI chr 7:89,731,626...89,764,761
Ensembl chr 7:89,730,232...89,765,436
|
|
G |
Fdps |
farnesyl diphosphate synthase |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of FDPS mRNA] |
CTD |
PMID:27256343 |
|
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
|
|
G |
Fen1 |
flap structure-specific endonuclease 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of FEN1 mRNA |
CTD |
PMID:33244087 PMID:36519830 |
|
NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
|
|
G |
Fgd3 |
FYVE, RhoGEF and PH domain containing 3 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of FGD3 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr17:15,324,848...15,387,271
Ensembl chr17:15,336,837...15,385,712
|
|
G |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
increases expression |
ISO |
Cannabidiol results in increased expression of FGD4 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr11:84,399,885...84,551,013
Ensembl chr11:84,399,816...84,546,972
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
decreases expression multiple interactions |
ISO |
Cannabidiol results in decreased expression of FGF1 mRNA Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of FGF1 protein] |
CTD |
PMID:30825431 PMID:33244087 |
|
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Fgf12 |
fibroblast growth factor 12 |
affects methylation |
EXP |
Cannabidiol affects the methylation of FGF12 gene |
CTD |
PMID:30521419 |
|
NCBI chr11:71,997,049...72,564,965
Ensembl chr11:71,997,099...72,562,607
|
|
G |
Fgf14 |
fibroblast growth factor 14 |
affects methylation |
EXP |
Cannabidiol affects the methylation of FGF14 gene |
CTD |
PMID:30521419 |
|
NCBI chr15:101,045,038...101,679,888
Ensembl chr15:101,045,036...101,679,900
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
multiple interactions increases expression |
ISO |
Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of FGF2 protein] Cannabidiol results in increased expression of FGF2 mRNA |
CTD |
PMID:27918106 PMID:30825431 PMID:36519830 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
increases expression multiple interactions |
ISO |
Cannabidiol analog results in increased expression of FGF21 mRNA Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of FGF21 protein]; Cannabidiol analog inhibits the reaction [Dietary Fats results in increased expression of FGF21 mRNA] |
CTD |
PMID:30382123 PMID:30825431 |
|
NCBI chr 1:96,083,495...96,084,738
Ensembl chr 1:96,083,441...96,090,454
|
|
G |
Fgf7 |
fibroblast growth factor 7 |
multiple interactions increases expression |
ISO |
Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of FGF7 protein] Cannabidiol results in increased expression of FGF7 mRNA Cannabidiol inhibits the reaction [TNF protein results in increased expression of FGF7 mRNA] |
CTD |
PMID:27918106 PMID:30825431 PMID:31250491 |
|
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
affects methylation |
EXP |
Cannabidiol affects the methylation of FGFR2 gene |
CTD |
PMID:30521419 |
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fgfr4 |
fibroblast growth factor receptor 4 |
affects methylation |
EXP |
Cannabidiol affects the methylation of FGFR4 gene |
CTD |
PMID:30521419 |
|
NCBI chr17:9,461,541...9,476,268
Ensembl chr17:9,461,547...9,476,242
|
|
G |
Fhl1 |
four and a half LIM domains 1 |
decreases methylation |
ISO |
Cannabidiol results in decreased methylation of FHL1 gene |
CTD |
PMID:33407853 |
|
NCBI chr X:134,555,399...134,614,930
Ensembl chr X:134,555,479...134,614,928
|
|
G |
Fis1 |
fission, mitochondrial 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of FIS1 mRNA |
CTD |
PMID:27714895 |
|
NCBI chr12:19,708,558...19,723,392
Ensembl chr12:19,708,558...19,723,377
|
|
G |
Fitm2 |
fat storage-inducing transmembrane protein 2 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of FITM2 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 3:152,141,346...152,147,858
Ensembl chr 3:152,141,346...152,147,858
|
|
G |
Fkbp4 |
FKBP prolyl isomerase 4 |
increases expression |
ISO |
Cannabidiol results in increased expression of FKBP4 mRNA |
CTD |
PMID:27714895 |
|
NCBI chr 4:161,703,379...161,711,833
Ensembl chr 4:161,703,379...161,711,833
|
|
G |
Fkbp8 |
FKBP prolyl isomerase 8 |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of FKBP8 protein |
CTD |
PMID:34122009 |
|
NCBI chr16:18,895,608...18,902,648
Ensembl chr16:18,893,576...18,902,612
|
|
G |
Flnc |
filamin C |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of FLNC protein |
CTD |
PMID:34122009 |
|
NCBI chr 4:58,034,088...58,061,882
Ensembl chr 4:58,034,189...58,061,844
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of FLT1 mRNA |
CTD |
PMID:33872753 |
|
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Flt3lg |
Fms related receptor tyrosine kinase 3 ligand |
decreases expression |
ISO |
Cannabidiol results in decreased expression of FLT3LG mRNA |
CTD |
PMID:27932991 |
|
NCBI chr 1:95,615,056...95,620,463
Ensembl chr 1:95,609,370...95,620,463
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
decreases expression multiple interactions increases expression |
ISO EXP |
Cannabidiol results in decreased expression of FOS mRNA [lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in decreased expression of FOS mRNA Cannabidiol results in increased expression of FOS mRNA Cannabidiol results in decreased expression of FOS protein |
CTD |
PMID:21542829 PMID:27918106 PMID:28344069 PMID:30742662 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosb |
FosB proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Cannabidiol results in increased expression of FOSB mRNA |
CTD |
PMID:26504004 |
|
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
|
|
G |
Foxc2 |
forkhead box C2 |
increases expression |
ISO |
Cannabidiol results in increased expression of FOXC2 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr19:49,186,034...49,188,736
Ensembl chr19:49,185,662...49,188,737
|
|
G |
Foxd1 |
forkhead box D1 |
increases expression |
ISO |
Cannabidiol results in increased expression of FOXD1 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 2:29,702,558...29,704,978
Ensembl chr 2:29,702,558...29,704,978
|
|
G |
Foxo1 |
forkhead box O1 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of FOXO1 mRNA] |
CTD |
PMID:31953017 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of FTH1 mRNA |
CTD |
PMID:31518892 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Ftl1 |
ferritin light chain 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of FTL mRNA |
CTD |
PMID:31518892 |
|
NCBI chr 1:95,936,390...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725
|
|
G |
Ftmt |
ferritin mitochondrial |
multiple interactions |
EXP |
Cannabidiol inhibits the reaction [Iron Carbonyl Compounds results in decreased expression of FTMT protein] |
CTD |
PMID:29374603 |
|
NCBI chr18:45,758,874...45,760,123
Ensembl chr18:45,758,874...45,760,123
|
|
G |
Furin |
furin (paired basic amino acid cleaving enzyme) |
increases expression |
ISO |
Cannabidiol results in increased expression of FURIN mRNA |
CTD |
PMID:31801206 |
|
NCBI chr 1:134,348,142...134,361,182
Ensembl chr 1:134,348,144...134,364,314
|
|
G |
Fyco1 |
FYVE and coiled-coil domain autophagy adaptor 1 |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of FYCO1 protein |
CTD |
PMID:34122009 |
|
NCBI chr 8:123,412,105...123,479,315
Ensembl chr 8:123,412,112...123,479,021
|
|
G |
Fzd9 |
frizzled class receptor 9 |
affects methylation |
EXP |
Cannabidiol affects the methylation of FZD9 gene |
CTD |
PMID:30521419 |
|
NCBI chr12:21,427,084...21,429,398
Ensembl chr12:21,427,084...21,429,398
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
decreases expression |
ISO |
Cannabidiol results in decreased expression of G6PD protein |
CTD |
PMID:34122009 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gabra1 |
gamma-aminobutyric acid type A receptor subunit alpha 1 |
multiple interactions |
ISO |
[Dronabinol co-treated with Cannabidiol] inhibits the reaction [[APP gene mutant form co-treated with PSEN1 gene mutant form] results in decreased expression of GABRA1 protein] |
CTD |
PMID:27567873 |
|
NCBI chr10:26,595,151...26,650,611
Ensembl chr10:26,595,160...26,650,864
|
|
G |
Gad1 |
glutamate decarboxylase 1 |
multiple interactions |
EXP |
Cannabidiol inhibits the reaction [Poly I-C results in decreased expression of GAD1 protein] |
CTD |
PMID:31202911 |
|
NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of GADD45A mRNA [Dronabinol co-treated with Cannabidiol] results in increased expression of GADD45A mRNA |
CTD |
PMID:21542829 PMID:26504004 PMID:36519830 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
increases expression |
ISO |
Cannabidiol results in increased expression of GADD45B mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
increases expression |
ISO |
Cannabidiol results in increased expression of GADD45G mRNA |
CTD |
PMID:36519830 |
|
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
|
|
G |
Galc |
galactosylceramidase |
decreases expression |
ISO |
Cannabidiol results in decreased expression of GALC mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 6:117,452,888...117,522,281
Ensembl chr 6:117,452,895...117,515,830
|
|
G |
Galnt2 |
polypeptide N-acetylgalactosaminyltransferase 2 |
decreases methylation |
ISO |
Cannabidiol results in decreased methylation of GALNT2 gene |
CTD |
PMID:32579259 |
|
NCBI chr19:52,213,226...52,324,816
Ensembl chr19:52,213,351...52,324,813
|
|
G |
Ganab |
glucosidase II alpha subunit |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of GANAB protein |
CTD |
PMID:34122009 |
|
NCBI chr 1:205,793,810...205,813,701
Ensembl chr 1:205,793,895...205,813,695
|
|
G |
Gap43 |
growth associated protein 43 |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of GAP43 protein |
CTD |
PMID:30096889 |
|
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
|
|
G |
Gas1 |
growth arrest-specific 1 |
multiple interactions increases expression decreases expression |
ISO |
[lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in increased expression of GAS1 mRNA Cannabidiol results in increased expression of GAS1 mRNA Cannabidiol results in decreased expression of GAS1 mRNA |
CTD |
PMID:27932991 PMID:30742662 |
|
NCBI chr17:4,482,014...4,485,155
|
|
G |
Gas7 |
growth arrest specific 7 |
multiple interactions increases expression |
ISO |
[Cannabidiol results in decreased expression of MIRLET7A1 mRNA] which results in increased expression of GAS7 mRNA Cannabidiol results in increased expression of GAS7 mRNA |
CTD |
PMID:30713602 |
|
NCBI chr10:52,152,728...52,383,276
Ensembl chr10:52,152,493...52,383,276
|
|
G |
Gatad2b |
GATA zinc finger domain containing 2B |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of GATAD2B protein |
CTD |
PMID:34122009 |
|
NCBI chr 2:175,748,594...175,829,837
Ensembl chr 2:175,749,433...175,825,542
|
|
G |
Gcg |
glucagon |
increases expression |
ISO |
Cannabidiol analog results in increased expression of GCG protein alternative form |
CTD |
PMID:30382123 |
|
NCBI chr 3:47,113,914...47,122,929
Ensembl chr 3:47,113,914...47,122,929
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
ISO |
Cannabidiol results in increased expression of GCLC mRNA |
CTD |
PMID:31518892 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
Cannabidiol results in increased expression of GCLM mRNA |
CTD |
PMID:21542829 PMID:31518892 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gdf1 |
growth differentiation factor 1 |
decreases methylation |
ISO |
Cannabidiol results in decreased methylation of GDF1 gene |
CTD |
PMID:33407853 |
|
NCBI chr16:19,097,309...19,112,519
Ensembl chr16:19,097,314...19,112,519
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of GDF15 mRNA [Dronabinol co-treated with Cannabidiol] results in increased expression of GDF15 mRNA |
CTD |
PMID:21542829 PMID:26504004 PMID:33244087 |
|
NCBI chr16:18,805,312...18,807,893
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gdf6 |
growth differentiation factor 6 |
affects methylation |
EXP |
Cannabidiol affects the methylation of GDF6 gene |
CTD |
PMID:30521419 |
|
NCBI chr 5:22,996,246...23,012,567
Ensembl chr 5:22,996,246...23,012,567
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of GFAP protein |
CTD |
PMID:30096889 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gfm2 |
GTP dependent ribosome recycling factor mitochondrial 2 |
increases expression |
ISO |
Cannabidiol results in increased expression of GFM2 protein |
CTD |
PMID:34122009 |
|
NCBI chr 2:28,449,452...28,488,200
Ensembl chr 2:28,449,517...28,488,197
|
|
G |
Gfod1 |
Gfo/Idh/MocA-like oxidoreductase domain containing 1 |
multiple interactions |
ISO |
Cannabidiol promotes the reaction [MOG protein modified form results in increased expression of GFOD1 mRNA] |
CTD |
PMID:27256343 |
|
NCBI chr17:21,400,142...21,504,972
Ensembl chr17:21,399,479...21,499,938
|
|
G |
Ggt6 |
gamma-glutamyl transferase 6 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of GGT6 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr10:57,052,025...57,054,502
Ensembl chr10:57,051,825...57,067,260
|
|
G |
Gins1 |
GINS complex subunit 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of GINS1 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 3:139,724,513...139,745,930
Ensembl chr 3:139,724,490...139,745,936
|
|
G |
Gins2 |
GINS complex subunit 2 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of GINS2 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr19:48,626,770...48,639,523
Ensembl chr19:48,626,770...48,639,339
|
|
G |
Gip |
gastric inhibitory polypeptide |
increases expression |
ISO |
Cannabidiol analog results in increased expression of GIP protein |
CTD |
PMID:30382123 |
|
NCBI chr10:80,968,410...80,976,506
Ensembl chr10:80,968,352...80,976,503
|
|
G |
Gk |
glycerol kinase |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of GK mRNA |
CTD |
PMID:30096889 |
|
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
|
|
G |
Glb1 |
galactosidase, beta 1 |
increases activity |
ISO |
Cannabidiol results in increased activity of GLB1 protein |
CTD |
PMID:36519830 |
|
NCBI chr 8:114,085,508...114,158,127
Ensembl chr 8:114,085,508...114,158,127
|
|
G |
Gli1 |
GLI family zinc finger 1 |
affects methylation |
EXP |
Cannabidiol affects the methylation of GLI1 gene |
CTD |
PMID:30521419 |
|
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
|
|
G |
Glrx2 |
glutaredoxin 2 |
increases expression |
ISO |
Cannabidiol results in increased expression of GLRX2 mRNA |
CTD |
PMID:27714895 |
|
NCBI chr13:55,481,875...55,504,737
Ensembl chr13:55,482,694...55,492,831
|
|
G |
Gnai2 |
G protein subunit alpha i2 |
increases expression |
ISO |
Cannabidiol results in increased expression of GNAI2 mRNA |
CTD |
PMID:33019509 |
|
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
|
|
G |
Gnal |
G protein subunit alpha L |
decreases expression |
ISO |
Cannabidiol results in decreased expression of GNAL mRNA |
CTD |
PMID:33019509 |
|
NCBI chr18:60,622,311...60,762,599
Ensembl chr18:60,622,311...60,762,599
|
|
G |
Gnao1 |
G protein subunit alpha o1 |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of GNAO1 protein |
CTD |
PMID:34122009 |
|
NCBI chr19:11,034,874...11,192,502
Ensembl chr19:11,035,956...11,192,493
|
|
G |
Gnb2 |
G protein subunit beta 2 |
affects methylation |
EXP |
Cannabidiol affects the methylation of GNB2 gene |
CTD |
PMID:30521419 |
|
NCBI chr12:19,159,002...19,164,021
Ensembl chr12:19,158,973...19,164,019
|
|
G |
Gnb4 |
G protein subunit beta 4 |
increases expression |
ISO |
Cannabidiol results in increased expression of GNB4 mRNA |
CTD |
PMID:33019509 |
|
NCBI chr 2:115,360,746...115,400,680
Ensembl chr 2:115,364,918...115,400,579
|
|
G |
Gng10 |
G protein subunit gamma 10 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of GNG10 mRNA |
CTD |
PMID:27932991 |
|
NCBI chr 5:73,856,124...73,863,017
Ensembl chr 5:73,856,164...73,863,012
|
|
G |
Gng7 |
G protein subunit gamma 7 |
affects methylation |
EXP |
Cannabidiol affects the methylation of GNG7 gene |
CTD |
PMID:30521419 |
|
NCBI chr 7:8,697,458...8,761,239
Ensembl chr 7:8,697,521...8,761,240
|
|
G |
Gon7 |
GON7 subunit of KEOPS complex |
increases expression |
ISO |
Cannabidiol results in increased expression of GON7 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 6:121,882,565...121,898,452
Ensembl chr 6:121,885,694...121,898,643 Ensembl chr 6:121,885,694...121,898,643
|
|
G |
Got2 |
glutamic-oxaloacetic transaminase 2 |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in increased expression of GOT2 protein |
CTD |
PMID:34122009 |
|
NCBI chr19:9,174,304...9,199,995
Ensembl chr19:9,174,311...9,199,994
|
|
G |
Gpc6 |
glypican 6 |
decreases methylation |
ISO |
Cannabidiol results in decreased methylation of GPC6 gene |
CTD |
PMID:32579259 |
|
NCBI chr15:94,030,218...95,027,883
Ensembl chr15:94,029,884...95,024,006
|
|
G |
Gpnmb |
glycoprotein nmb |
increases expression |
ISO |
Cannabidiol results in increased expression of GPNMB mRNA |
CTD |
PMID:27256343 |
|
NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
|
|
G |
Gpr135 |
G protein-coupled receptor 135 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of GPR135 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 6:90,627,533...90,636,311
Ensembl chr 6:90,629,178...90,630,551
|
|
G |
Gpr183 |
G protein-coupled receptor 183 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of GPR183 mRNA |
CTD |
PMID:21542829 |
|
NCBI chr15:99,037,764...99,050,550
Ensembl chr15:99,036,367...99,050,559
|
|
G |
Gpr83 |
G protein-coupled receptor 83 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of GPR83 mRNA] |
CTD |
PMID:27256343 |
|
NCBI chr 8:11,693,540...11,704,028
Ensembl chr 8:11,693,540...11,704,028
|
|
G |
Gpr84 |
G protein-coupled receptor 84 |
multiple interactions |
EXP |
Cannabidiol inhibits the reaction [Ketamine results in decreased expression of GPR84 mRNA] |
CTD |
PMID:31823199 |
|
NCBI chr 7:134,443,904...134,446,173
Ensembl chr 7:134,443,936...134,446,178
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases expression |
ISO |
Cannabidiol results in increased expression of GPT protein |
CTD |
PMID:31052254 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpt2 |
glutamic--pyruvic transaminase 2 |
increases expression |
ISO |
Cannabidiol results in increased expression of GPT2 mRNA |
CTD |
PMID:21542829 |
|
NCBI chr19:21,526,800...21,561,314
Ensembl chr19:21,517,621...21,560,610
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
increases expression |
ISO |
Cannabidiol results in increased expression of GPX2 mRNA |
CTD |
PMID:31518892 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
increases expression |
ISO |
Cannabidiol results in increased expression of GPX3 mRNA |
CTD |
PMID:31518892 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Grb10 |
growth factor receptor bound protein 10 |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in decreased expression of GRB10 mRNA |
CTD |
PMID:30096889 |
|
NCBI chr14:86,495,054...86,602,815
Ensembl chr14:86,495,054...86,602,806
|
|
G |
Grb2 |
growth factor receptor bound protein 2 |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of GRB2 mRNA; [Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of GRB2 mRNA |
CTD |
PMID:30096889 PMID:32992648 |
|
NCBI chr10:100,881,404...100,949,193
Ensembl chr10:100,869,718...100,949,309
|
|
G |
Gria2 |
glutamate ionotropic receptor AMPA type subunit 2 |
multiple interactions |
ISO |
[Dronabinol co-treated with Cannabidiol] results in decreased susceptibility to [[APP gene mutant form co-treated with PSEN1 gene mutant form] results in decreased expression of GRIA2 protein] |
CTD |
PMID:27567873 |
|
NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510
|
|
G |
Gria3 |
glutamate ionotropic receptor AMPA type subunit 3 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of GRIA3 mRNA |
CTD |
PMID:27714895 |
|
NCBI chr X:120,238,515...120,504,106
Ensembl chr X:120,238,534...120,504,096
|
|
G |
Grik2 |
glutamate ionotropic receptor kainate type subunit 2 |
increases expression |
ISO |
Cannabidiol results in increased expression of GRIK2 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr20:52,135,325...52,833,061
Ensembl chr20:52,133,851...52,838,375
|
|
G |
Grip1 |
glutamate receptor interacting protein 1 |
decreases methylation |
ISO |
Cannabidiol results in decreased methylation of GRIP1 gene |
CTD |
PMID:33407853 |
|
NCBI chr 7:54,934,856...55,592,274
Ensembl chr 7:54,934,250...55,592,273
|
|
G |
Gsdmd |
gasdermin D |
decreases expression multiple interactions |
ISO |
Cannabidiol results in decreased expression of GSDMD protein 2-chloro-5-nitrobenzanilide inhibits the reaction [Cannabidiol inhibits the reaction [Lipopolysaccharides results in increased cleavage of GSDMD protein]]; Cannabidiol inhibits the reaction [Lipopolysaccharides results in increased cleavage of GSDMD protein] |
CTD |
PMID:34269108 |
|
NCBI chr 7:107,542,242...107,547,052
Ensembl chr 7:107,542,083...107,547,055
|
|
G |
Gse1 |
Gse1 coiled-coil protein |
decreases methylation |
ISO |
Cannabidiol results in decreased methylation of GSE1 gene |
CTD |
PMID:33407853 |
|
NCBI chr19:48,274,164...48,629,456
Ensembl chr19:48,274,127...48,629,458
|
|
G |
Gsk3a |
glycogen synthase kinase 3 alpha |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of GSK3A mRNA |
CTD |
PMID:30096889 |
|
NCBI chr 1:80,815,843...80,825,732
Ensembl chr 1:80,815,850...80,825,802
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
decreases expression multiple interactions |
ISO |
Cannabidiol results in decreased expression of GSK3B mRNA; Cannabidiol results in decreased expression of GSK3B protein; Cannabidiol results in decreased expression of GSK3B protein modified form [Cannabidiol co-treated with moringin] results in increased expression of GSK3B mRNA; capsazepine inhibits the reaction [Cannabidiol results in decreased expression of GSK3B protein modified form]; capsazepine inhibits the reaction [Cannabidiol results in decreased expression of GSK3B protein] |
CTD |
PMID:28025562 PMID:30096889 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsn |
gelsolin |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in increased expression of GSN protein |
CTD |
PMID:34122009 |
|
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
|
|
G |
Gsr |
glutathione-disulfide reductase |
decreases activity increases expression |
ISO |
Cannabidiol results in decreased activity of GSR protein Cannabidiol results in increased expression of GSR mRNA |
CTD |
PMID:18929579 PMID:31052254 PMID:32752303 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of GSTM1 mRNA |
CTD |
PMID:21542829 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of GSTP1 mRNA; Cannabidiol results in increased expression of GSTP1 protein |
CTD |
PMID:31518892 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gtf2f1 |
general transcription factor IIF subunit 1 |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of GTF2F1 protein |
CTD |
PMID:34122009 |
|
NCBI chr 9:1,844,027...1,853,455
Ensembl chr 9:1,843,901...1,853,423
|
|
G |
Gtse1 |
G-2 and S-phase expressed 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of GTSE1 mRNA |
CTD |
PMID:36519830 |
|
NCBI chr 7:116,949,997...116,966,826
Ensembl chr 7:116,950,053...116,966,806
|
|
G |
Gys1 |
glycogen synthase 1 |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of GYS1 mRNA |
CTD |
PMID:30096889 |
|
NCBI chr 1:95,915,443...95,935,292
Ensembl chr 1:95,915,443...95,935,292
|
|
G |
H1f2 |
H1.2 linker histone, cluster member |
increases expression |
ISO |
Cannabidiol results in increased expression of H1F2 mRNA |
CTD |
PMID:21542829 |
|
NCBI chr17:41,391,106...41,392,611
Ensembl chr17:41,388,477...41,392,635
|
|
G |
H1f5 |
H1.5 linker histone, cluster member |
decreases expression |
ISO |
Cannabidiol results in decreased expression of H1-5 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr17:42,726,189...42,726,857
Ensembl chr17:42,726,127...42,769,160
|
|
G |
H2ac12 |
H2A clustered histone 12 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of H2AC12 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr17:42,486,315...42,486,880
Ensembl chr17:42,486,415...42,486,941
|
|
G |
H2ac20 |
H2A clustered histone 20 |
increases expression |
ISO |
Cannabidiol results in increased expression of H2AC20 protein |
CTD |
PMID:34122009 |
|
NCBI chr 2:183,779,879...183,780,324
|
|
G |
H2ac4 |
H2A clustered histone 4 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of H2AC4 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr17:42,799,953...42,800,345
Ensembl chr17:42,799,652...42,800,381
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions increases expression |
ISO |
Cannabidiol promotes the reaction [Dronabinol results in increased expression of H2AX protein modified form]; Dronabinol promotes the reaction [Cannabidiol results in increased expression of H2AX protein modified form] |
CTD |
PMID:27769052 |
|
NCBI chr 8:44,671,927...44,673,257
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
H3c1 |
H3 clustered histone 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of H3C1 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr17:41,367,824...41,368,902
Ensembl chr17:41,368,386...41,368,856
|
|
G |
Hacd3 |
3-hydroxyacyl-CoA dehydratase 3 |
increases expression |
ISO |
Cannabidiol results in increased expression of HACD3 protein |
CTD |
PMID:34122009 |
|
NCBI chr 8:65,501,240...65,538,507
Ensembl chr 8:65,501,240...65,538,507
|
|
G |
Hap1 |
huntingtin-associated protein 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of HAP1 mRNA |
CTD |
PMID:33019509 |
|
NCBI chr10:85,277,890...85,286,126
Ensembl chr10:85,277,890...85,286,126
|
|
G |
Has2 |
hyaluronan synthase 2 |
increases expression |
ISO |
Cannabidiol results in increased expression of HAS2 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 7:88,113,326...88,139,337
Ensembl chr 7:88,113,326...88,128,933
|
|
G |
Hat1 |
histone acetyltransferase 1 |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of HAT1 protein |
CTD |
PMID:34122009 |
|
NCBI chr 3:56,217,344...56,265,021
Ensembl chr 3:56,217,342...56,275,517
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
increases expression |
ISO |
Cannabidiol results in increased expression of HBEGF mRNA |
CTD |
PMID:31518892 PMID:33244087 |
|
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
|
|
G |
Hbp1 |
HMG-box transcription factor 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of HBP1 mRNA |
CTD |
PMID:30742662 |
|
NCBI chr 6:48,529,633...48,555,775
Ensembl chr 6:48,529,372...48,555,787
|
|
G |
Hcls1 |
hematopoietic cell specific Lyn substrate 1 |
multiple interactions |
ISO |
Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of HCLS1 mRNA] |
CTD |
PMID:30825431 |
|
NCBI chr11:63,817,482...63,840,943
Ensembl chr11:63,817,476...63,841,014
|
|
G |
Hcrtr1 |
hypocretin receptor 1 |
multiple interactions |
ISO |
Cannabidiol binds to and results in decreased activity of HCRTR1 protein |
CTD |
PMID:34439801 |
|
NCBI chr 5:142,477,214...142,486,674
Ensembl chr 5:142,477,214...142,486,674
|
|
G |
Helb |
DNA helicase B |
increases expression |
ISO |
Cannabidiol results in increased expression of HELB mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 7:55,588,510...55,615,979
Ensembl chr 7:55,588,798...55,615,585
|
|
G |
Herpud1 |
homocysteine inducible ER protein with ubiquitin like domain 1 |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of HERPUD1 mRNA [Dronabinol co-treated with Cannabidiol] results in increased expression of HERPUD1 mRNA |
CTD |
PMID:21542829 PMID:26504004 PMID:27714895 PMID:33244087 |
|
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
|
|
G |
Hes2 |
hes family bHLH transcription factor 2 |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of HES2 mRNA [lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in decreased expression of HES2 mRNA |
CTD |
PMID:30742662 |
|
NCBI chr 5:162,667,190...162,668,235
Ensembl chr 5:162,667,190...162,668,235
|
|
G |
Hgf |
hepatocyte growth factor |
affects methylation multiple interactions |
EXP ISO |
Cannabidiol affects the methylation of HGF gene Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of HGF protein] |
CTD |
PMID:30521419 PMID:30825431 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
increases expression |
EXP ISO |
Cannabidiol analog results in increased expression of HIF1A protein Cannabidiol results in increased expression of HIF1A mRNA |
CTD |
PMID:30382123 PMID:34302491 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hip1 |
huntingtin interacting protein 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of HIP1 protein |
CTD |
PMID:34122009 |
|
NCBI chr12:21,133,319...21,267,796
Ensembl chr12:21,133,406...21,267,725
|
|
G |
Hist1h2ah |
histone cluster 1 H2A family member H |
decreases expression |
ISO |
Cannabidiol results in decreased expression of H2AC11 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr17:41,384,521...41,385,018
|
|
G |
Hist1h2ail1 |
histone cluster 1 H2a family member I like 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of H3C6 mRNA |
CTD |
PMID:21542829 |
|
NCBI chr17:41,568,666...41,569,076
Ensembl chr17:41,568,471...41,569,109
|
|
G |
Hist1h2bd |
histone cluster 1 H2B family member D |
increases expression |
ISO |
Cannabidiol results in increased expression of H2BC21 mRNA |
CTD |
PMID:21542829 |
|
NCBI chr17:42,792,887...42,793,268
|
|
G |
Hist1h3b |
histone cluster 1, H3b |
decreases expression |
ISO |
Cannabidiol results in decreased expression of H3C12 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr17:42,722,805...42,723,925
Ensembl chr17:42,723,450...42,723,911
|
|
G |
Hist1h4b |
histone cluster 1 H4 family member B |
increases expression |
ISO |
Cannabidiol results in increased expression of H4C9 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr17:42,480,467...42,484,912
Ensembl chr17:42,480,313...42,485,370
|
|
G |
Hist1h4m |
histone cluster 1, H4m |
decreases expression |
ISO |
Cannabidiol results in decreased expression of H4C1 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr17:42,698,054...42,698,365
Ensembl chr17:42,698,025...42,698,958
|
|
G |
Hist2h4 |
histone cluster 2, H4 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of H4C2 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 2:183,831,601...183,831,996
Ensembl chr 2:183,825,994...183,832,048
|
|
G |
Hist2h4a |
histone cluster 2 H4 family member A |
decreases expression |
ISO |
Cannabidiol results in decreased expression of H4C4 mRNA |
CTD |
PMID:33244087 |
|
|
|
G |
Hmga2 |
high mobility group AT-hook 2 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of HMGA2 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 7:55,877,145...55,998,813
Ensembl chr 7:55,880,112...55,994,784
|
|
G |
Hmgb2 |
high mobility group box 2 |
increases expression |
ISO |
Cannabidiol results in increased expression of HMGB2 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of HMGCS1 protein |
CTD |
PMID:34122009 |
|
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions affects response to substance |
ISO |
Cannabidiol results in increased expression of HMOX1 mRNA; Cannabidiol results in increased expression of HMOX1 protein [bafilomycin A1 co-treated with tin protoporphyrin IX] promotes the reaction [Cannabidiol results in increased expression of HMOX1 protein]; [Dronabinol co-treated with Cannabidiol] results in increased expression of HMOX1 mRNA; Acetylcysteine inhibits the reaction [Cannabidiol results in increased expression of HMOX1 protein]; BACH1 protein affects the reaction [Cannabidiol results in increased expression of HMOX1 mRNA]; BACH1 protein affects the reaction [Cannabidiol results in increased expression of HMOX1 protein]; iodopravadoline promotes the reaction [Cannabidiol results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [Cannabidiol results in increased expression of HMOX1 protein]; tin protoporphyrin IX promotes the reaction [Cannabidiol results in increased expression of HMOX1 protein] HMOX1 protein affects the susceptibility to Cannabidiol [lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in increased expression of HMOX1 mRNA; [Rotenone co-treated with Bilirubin] inhibits the reaction [Cannabidiol results in increased expression of HMOX1 mRNA]; Bilirubin inhibits the reaction [Cannabidiol results in increased expression of HMOX1 mRNA]; Rotenone promotes the reaction [Cannabidiol results in increased expression of HMOX1 mRNA] |
CTD |
PMID:21542829 PMID:26504004 PMID:30349652 PMID:30742662 PMID:31052254 PMID:31518892 PMID:32033040 PMID:32708634 PMID:33076330 More...
|
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnf1a |
HNF1 homeobox A |
affects methylation |
EXP |
Cannabidiol affects the methylation of HNF1A gene |
CTD |
PMID:30521419 |
|
NCBI chr12:41,638,536...41,672,806
Ensembl chr12:41,645,587...41,672,104
|
|
G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of HNRNPA1 protein |
CTD |
PMID:34122009 |
|
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
|
|
G |
Hnrnpk |
heterogeneous nuclear ribonucleoprotein K |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of HNRNPK protein |
CTD |
PMID:34122009 |
|
NCBI chr17:6,262,936...6,275,001
Ensembl chr17:6,262,998...6,274,997
|
|
G |
Hp |
haptoglobin |
increases expression |
ISO |
Cannabidiol results in increased expression of HP mRNA |
CTD |
PMID:21542829 |
|
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
|
|
G |
Hps6 |
HPS6, biogenesis of lysosomal organelles complex 2 subunit 3 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of HPS6 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 1:244,853,256...244,855,865
Ensembl chr 1:244,853,194...244,855,883
|
|
G |
Hrc |
histidine rich calcium binding protein |
decreases expression |
ISO |
Cannabidiol results in decreased expression of HRC protein |
CTD |
PMID:34122009 |
|
NCBI chr 1:95,813,262...95,816,987
Ensembl chr 1:95,813,253...95,816,984
|
|
G |
Hrh1 |
histamine receptor H 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of HRH1 mRNA |
CTD |
PMID:27918106 |
|
NCBI chr 4:147,564,781...147,649,353
Ensembl chr 4:147,645,995...147,647,455
|
|
G |
Hrob |
homologous recombination factor with OB-fold |
increases expression |
ISO |
Cannabidiol results in increased expression of HROB mRNA |
CTD |
PMID:27918106 |
|
NCBI chr10:87,206,017...87,222,483
Ensembl chr10:87,206,049...87,222,483
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
multiple interactions increases expression |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of HSP90AA1 mRNA Cannabidiol results in increased expression of HSP90AA1 mRNA |
CTD |
PMID:27932991 PMID:28025562 PMID:30096889 |
|
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha family class B member 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of HSP90AB1 mRNA |
CTD |
PMID:28025562 |
|
NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
|
|
G |
Hsp90b1 |
heat shock protein 90 beta family member 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of HSP90B1 mRNA; Cannabidiol results in increased expression of HSP90B1 protein |
CTD |
PMID:28025562 PMID:31699976 |
|
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
|
|
G |
Hspa13 |
heat shock protein family A (Hsp70) member 13 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of HSPA13 mRNA |
CTD |
PMID:27714895 |
|
NCBI chr11:14,375,669...14,389,853
Ensembl chr11:14,373,275...14,389,895
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of HSPA1B mRNA [Dronabinol co-treated with Cannabidiol] results in increased expression of HSPA1B mRNA |
CTD |
PMID:26504004 |
|
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
increases expression |
ISO |
Cannabidiol results in increased expression of HSPA1A mRNA |
CTD |
PMID:26504004 PMID:31518892 |
|
NCBI chr20:3,870,765...3,873,221
|
|
G |
Hspa2 |
heat shock protein family A (Hsp70) member 2 |
decreases expression multiple interactions increases expression |
ISO |
Cannabidiol results in decreased expression of HSPA2 mRNA [Cuprizone co-treated with Cannabidiol] results in decreased expression of HSPA2 protein Cannabidiol results in increased expression of HSPA2 mRNA |
CTD |
PMID:28025562 PMID:33244087 PMID:34122009 |
|
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
|
|
G |
Hspa4 |
heat shock protein family A (Hsp70) member 4 |
multiple interactions increases expression |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of HSPA4 mRNA Cannabidiol results in increased expression of HSPA4 mRNA |
CTD |
PMID:28025562 PMID:30096889 |
|
NCBI chr10:37,408,025...37,449,080
Ensembl chr10:37,408,025...37,449,001
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions increases expression |
ISO |
[Cannabidiol co-treated with Rotenone] results in increased expression of HSPA5 mRNA; Bilirubin inhibits the reaction [[Cannabidiol co-treated with Rotenone] results in increased expression of HSPA5 mRNA] Cannabidiol results in increased expression of HSPA5 mRNA; Cannabidiol results in increased expression of HSPA5 protein |
CTD |
PMID:28025562 PMID:31699976 PMID:32033040 PMID:33244087 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspa6l-ps1 |
heat shock protein family A (Hsp70) member 6 like, pseudogene 1 |
increases expression |
ISO |
Cannabidiol results in increased expression of HSPA6 mRNA |
CTD |
PMID:26504004 |
|
NCBI chr13:83,271,340...83,275,267
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
multiple interactions increases expression |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of HSPA8 protein Cannabidiol results in increased expression of HSPA8 mRNA |
CTD |
PMID:28025562 PMID:34122009 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of HSPB1 mRNA [Cannabidiol co-treated with moringin] results in increased expression of HSPB1 mRNA |
CTD |
PMID:27714895 PMID:30096889 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
increases expression |
ISO |
Cannabidiol results in increased expression of HTATIP2 mRNA |
CTD |
PMID:21542829 |
|
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
|
|
G |
Htr1a |
5-hydroxytryptamine receptor 1A |
multiple interactions affects expression |
ISO |
[Cannabidiol co-treated with Naltrexone] results in decreased expression of HTR1A mRNA Cannabidiol affects the expression of HTR1A mRNA |
CTD |
PMID:29859012 PMID:30324842 |
|
NCBI chr 2:36,694,174...36,695,442
Ensembl chr 2:36,694,174...36,695,442
|
|
G |
Htr1d |
5-hydroxytryptamine receptor 1D |
decreases expression |
ISO |
Cannabidiol results in decreased expression of HTR1D mRNA |
CTD |
PMID:33244087 |
|
NCBI chr 5:148,655,979...148,676,534
Ensembl chr 5:148,674,495...148,675,619
|
|
G |
Htra2 |
HtrA serine peptidase 2 |
multiple interactions decreases expression |
ISO |
[Cannabidiol co-treated with moringin] results in decreased expression of HTRA2 mRNA Cannabidiol results in decreased expression of HTRA2 mRNA |
CTD |
PMID:27714895 PMID:30096889 |
|
NCBI chr 4:115,556,914...115,560,202
Ensembl chr 4:115,556,916...115,560,095
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions increases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Cannabidiol results in increased expression of ICAM1 mRNA]; AM 251 inhibits the reaction [Cannabidiol results in increased expression of ICAM1 mRNA]; Cannabidiol inhibits the reaction [MLLT11 protein results in decreased expression of ICAM1 protein]; capsazepine inhibits the reaction [Cannabidiol results in increased expression of ICAM1 mRNA]; ICAM1 mutant form inhibits the reaction [Cannabidiol results in increased expression of TIMP1 protein]; iodopravadoline inhibits the reaction [Cannabidiol results in increased expression of ICAM1 mRNA] Cannabidiol results in increased expression of ICAM1 mRNA; Cannabidiol results in increased expression of ICAM1 protein [Plant Extracts results in increased abundance of Cannabidiol] which results in increased expression of ICAM1 mRNA |
CTD |
PMID:22198381 PMID:31052254 PMID:31587870 PMID:32400224 PMID:33872753 PMID:36519830 More...
|
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Id1 |
inhibitor of DNA binding 1 |
decreases expression affects response to substance |
ISO |
Cannabidiol results in decreased expression of ID1 mRNA; Cannabidiol results in decreased expression of ID1 protein ID1 protein affects the susceptibility to Cannabidiol |
CTD |
PMID:21542829 PMID:24910342 |
|
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
|
|
G |
Ide |
insulin degrading enzyme |
increases expression |
ISO |
Cannabidiol results in increased expression of IDE mRNA |
CTD |
PMID:28025562 |
|
NCBI chr 1:235,002,984...235,102,448
Ensembl chr 1:234,995,351...235,102,440
|
|
G |
Idh3a |
isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha |
multiple interactions increases expression |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of IDH3A mRNA Cannabidiol results in increased expression of IDH3A mRNA |
CTD |
PMID:27714895 PMID:30096889 |
|
NCBI chr 8:54,971,694...54,991,085
Ensembl chr 8:54,971,740...54,991,084
|
|
G |
Idh3g |
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in increased expression of IDH3G mRNA |
CTD |
PMID:30096889 |
|
NCBI chr X:151,515,244...151,524,175
Ensembl chr X:151,515,247...151,524,171
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
multiple interactions |
ISO |
AM 281 promotes the reaction [Cannabidiol inhibits the reaction [Plant Preparations results in increased activity of IDO1 protein]]; Cannabidiol inhibits the reaction [[Plant Preparations results in increased activity of IDO1 protein] which results in increased abundance of Neopterin]; Cannabidiol inhibits the reaction [Plant Preparations results in increased activity of IDO1 protein]; Cannabidiol inhibits the reaction [Plant Preparations results in increased expression of IDO1 mRNA]; iodopravadoline promotes the reaction [Cannabidiol inhibits the reaction [Plant Preparations results in increased activity of IDO1 protein]] |
CTD |
PMID:19167098 |
|
NCBI chr16:67,430,684...67,442,459
Ensembl chr16:67,430,578...67,442,730
|
|
G |
Ier3 |
immediate early response 3 |
multiple interactions increases expression |
ISO |
Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of IER3 mRNA] Cannabidiol results in increased expression of IER3 mRNA |
CTD |
PMID:27256343 PMID:33244087 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Ifitm1 |
interferon induced transmembrane protein 1 |
multiple interactions |
ISO |
Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of IFITM1 mRNA] |
CTD |
PMID:30825431 |
|
NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:196,067,963...196,069,169
|
|
G |
Ifnb1 |
interferon beta 1 |
multiple interactions increases expression |
ISO |
[lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in decreased expression of IFNB1 mRNA; Cannabidiol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IFNB1 mRNA]; Cannabidiol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IFNB1 protein] Cannabidiol results in increased expression of IFNB1 mRNA [Dronabinol co-treated with Cannabidiol] inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 protein]; [Dronabinol co-treated with Cannabidiol] inhibits the reaction [Poly I-C results in increased expression of IFNB1 mRNA]; Cannabidiol inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 protein]; Cannabidiol inhibits the reaction [Poly I-C results in increased expression of IFNB1 mRNA] |
CTD |
PMID:19910459 PMID:21542829 PMID:30742662 PMID:32244040 |
|
NCBI chr 5:103,020,969...103,021,523
Ensembl chr 5:103,020,969...103,021,523
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
[Cannabidiol co-treated with TNF protein co-treated with IFNG protein] results in increased expression of AQP3 mRNA; [Dronabinol co-treated with Cannabidiol] inhibits the reaction [IFNG protein results in increased expression of PSMB8 mRNA]; [Dronabinol co-treated with Cannabidiol] inhibits the reaction [IFNG protein results in increased expression of PSMB8 protein]; Cannabidiol affects the reaction [Plant Preparations results in increased secretion of IFNG protein]; Cannabidiol inhibits the reaction [[TNF protein co-treated with IFNG protein] results in decreased expression of TRPV1 mRNA]; Cannabidiol inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased expression of AQP3 mRNA]; Cannabidiol inhibits the reaction [IFNG protein results in increased expression of PSMB8 mRNA]; Cannabidiol inhibits the reaction [IFNG protein results in increased expression of PSMB8 protein]; Cannabidiol inhibits the reaction [Plant Preparations results in increased expression of IFNG mRNA]; Cannabidiol promotes the reaction [Dronabinol inhibits the reaction [IFNG protein results in increased expression of PSMB8 mRNA]]; Dronabinol promotes the reaction [Cannabidiol inhibits the reaction [IFNG results in increased expression of PSMB8 mRNA]] Cannabidiol inhibits the reaction [[myelin oligodendrocyte glycoprotein (35-55) results in increased susceptibility to myelin oligodendrocyte glycoprotein (35-55)] which results in increased expression of and results in increased secretion of IFNG protein] |
CTD |
PMID:19167098 PMID:27769052 PMID:30123217 PMID:31054246 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ifngr1 |
interferon gamma receptor 1 |
multiple interactions decreases expression |
ISO |
Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of IFNGR1 mRNA] Cannabidiol results in decreased expression of IFNGR1 mRNA |
CTD |
PMID:27256343 PMID:27932991 |
|
NCBI chr 1:14,333,167...14,351,799
Ensembl chr 1:14,333,187...14,351,785
|
|
G |
Ifngr2 |
interferon gamma receptor 2 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of IFNGR2 mRNA |
CTD |
PMID:27932991 |
|
NCBI chr11:30,779,733...30,798,005
Ensembl chr11:30,779,733...30,798,005
|
|
G |
Igfals |
insulin-like growth factor binding protein, acid labile subunit |
decreases expression |
ISO |
Cannabidiol results in decreased expression of IGFALS mRNA |
CTD |
PMID:31052254 |
|
NCBI chr10:13,897,468...13,903,920
Ensembl chr10:13,898,395...13,902,677
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA] |
CTD |
PMID:31953017 |
|
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
|
|
G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
decreases expression multiple interactions |
ISO |
Cannabidiol results in decreased expression of IGFBP4 mRNA Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of IGFBP4 mRNA] |
CTD |
PMID:21542829 PMID:27256343 |
|
NCBI chr10:83,995,253...84,007,272
Ensembl chr10:83,989,591...84,007,225
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in decreased expression of IKBKB mRNA |
CTD |
PMID:30096889 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Ikbkg |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
multiple interactions |
ISO |
[Cannabidiol co-treated with moringin] results in decreased expression of IKBKG mRNA |
CTD |
PMID:30096889 |
|
NCBI chr X:152,216,485...152,241,476
Ensembl chr X:152,216,596...152,239,499
|
|
G |
Il10 |
interleukin 10 |
increases expression decreases expression multiple interactions |
ISO EXP |
Cannabidiol results in increased expression of IL10 protein Cannabidiol results in decreased expression of IL10 mRNA [Cannabidiol co-treated with Haloperidol] results in increased expression of IL10 protein; Cannabidiol inhibits the reaction [[myelin oligodendrocyte glycoprotein (35-55) results in increased susceptibility to myelin oligodendrocyte glycoprotein (35-55)] which results in decreased expression of IL10 mRNA]; Cannabidiol promotes the reaction [[myelin oligodendrocyte glycoprotein (35-55) results in increased susceptibility to myelin oligodendrocyte glycoprotein (35-55)] which results in increased expression of and results in increased secretion of IL10 protein]; Cannabidiol promotes the reaction [Lipopolysaccharides results in increased expression of IL10 protein] Cannabidiol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein] |
CTD |
PMID:30123217 PMID:30217539 PMID:30793820 PMID:32345916 PMID:34740670 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il11ra1 |
interleukin 11 receptor subunit alpha 1 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of IL11RA mRNA |
CTD |
PMID:27932991 |
|
NCBI chr 5:56,931,824...56,941,408
Ensembl chr 5:56,935,516...56,941,408
|
|
G |
Il12a |
interleukin 12A |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of IL12A mRNA] |
CTD |
PMID:27256343 |
|
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
|
|
G |
Il13 |
interleukin 13 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [TNF protein results in decreased expression of IL13 mRNA] |
CTD |
PMID:31250491 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il13ra1 |
interleukin 13 receptor subunit alpha 1 |
decreases expression multiple interactions |
ISO |
Cannabidiol results in decreased expression of IL13RA1 mRNA Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of IL13RA1 mRNA] |
CTD |
PMID:27932991 PMID:30825431 |
|
NCBI chr X:115,348,860...115,408,682
Ensembl chr X:115,348,860...115,408,681
|
|
G |
Il15 |
interleukin 15 |
increases expression |
ISO |
Cannabidiol results in increased expression of IL15 mRNA |
CTD |
PMID:36519830 |
|
NCBI chr19:25,640,013...25,706,818
Ensembl chr19:25,640,251...25,706,820
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [[myelin oligodendrocyte glycoprotein (35-55) results in increased susceptibility to myelin oligodendrocyte glycoprotein (35-55)] which results in increased expression of and results in increased secretion of IL17A protein] |
CTD |
PMID:30123217 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il17c |
interleukin 17C |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [TNF protein results in increased expression of IL17C mRNA] |
CTD |
PMID:31250491 |
|
NCBI chr19:50,484,890...50,486,169
Ensembl chr19:50,484,890...50,486,169
|
|
G |
Il18 |
interleukin 18 |
multiple interactions decreases expression |
ISO |
iodopravadoline inhibits the reaction [Cannabidiol results in decreased expression of IL18 protein]; Rimonabant inhibits the reaction [Cannabidiol results in decreased expression of IL18 protein] Cannabidiol results in decreased expression of IL18 mRNA; Cannabidiol results in decreased expression of IL18 protein |
CTD |
PMID:27932991 PMID:34269108 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression multiple interactions |
ISO |
Cannabidiol results in increased expression of IL1A mRNA [Plant Extracts results in increased abundance of Cannabidiol] which results in increased expression of IL1A mRNA |
CTD |
PMID:32400224 PMID:33244087 PMID:36519830 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions decreases expression decreases secretion increases expression |
ISO EXP |
[Bleomycin co-treated with Cannabidiol analog] results in decreased expression of IL1B mRNA; Cannabidiol inhibits the reaction [Ethanol results in increased expression of IL1B mRNA]; Cannabidiol inhibits the reaction [Haloperidol results in increased expression of IL1B protein]; Cannabidiol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL1B mRNA]; Cannabidiol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL1B protein]; Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of IL1B mRNA]; Cannabidiol inhibits the reaction [MOG protein modified form results in increased secretion of IL1B protein] Cannabidiol results in decreased expression of IL1B mRNA; Cannabidiol results in decreased expression of IL1B protein Cannabidiol inhibits the reaction [Hydrogen Peroxide results in increased expression of IL1B protein]; Cannabidiol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein] 2-chloro-5-nitrobenzanilide inhibits the reaction [Cannabidiol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; [Cannabidiol co-treated with CpG ODN 2395] results in decreased secretion of IL1B protein; Cannabidiol inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of IL1B protein]; Cannabidiol inhibits the reaction [Hydrogen Peroxide results in increased expression of IL1B mRNA]; Cannabidiol inhibits the reaction [Hydrogen Peroxide results in increased expression of IL1B protein]; Cannabidiol inhibits the reaction [Imiquimod results in increased secretion of IL1B protein]; Cannabidiol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Cannabidiol inhibits the reaction [Pam(3)CSK(4) peptide results in increased secretion of IL1B protein]; Cannabidiol inhibits the reaction [TNF protein results in increased expression of IL1B mRNA] Cannabidiol results in decreased secretion of IL1B protein Cannabidiol results in increased expression of IL1B mRNA |
CTD |
PMID:19910459 PMID:21492165 PMID:21542829 PMID:27256343 PMID:27430346 PMID:27932991 PMID:28935932 PMID:30033591 PMID:30217539 PMID:30793820 PMID:31250491 PMID:33955754 PMID:34269108 PMID:34740670 PMID:36519830 More...
|
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r1 |
interleukin 1 receptor type 1 |
multiple interactions decreases expression |
ISO |
Cannabidiol inhibits the reaction [TNF protein results in decreased expression of IL1R1 mRNA] Cannabidiol results in decreased expression of IL1R1 mRNA |
CTD |
PMID:27932991 PMID:31250491 PMID:31801206 |
|
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
|
|
G |
Il2 |
interleukin 2 |
increases secretion multiple interactions |
ISO |
Cannabidiol results in increased secretion of IL2 protein [Plant Extracts results in increased abundance of Cannabidiol] which results in increased expression of IL2 mRNA Cannabidiol promotes the reaction [Pam(3)CSK(4) peptide results in increased secretion of IL2 protein] |
CTD |
PMID:11809870 PMID:32400224 PMID:34740670 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il24 |
interleukin 24 |
increases expression |
ISO |
Cannabidiol results in increased expression of IL24 mRNA |
CTD |
PMID:33244087 |
|
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
|
|
G |
Il3 |
interleukin 3 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of IL3 mRNA]; Cannabidiol inhibits the reaction [MOG protein modified form results in increased secretion of IL3 protein] |
CTD |
PMID:27256343 |
|
NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of IL4 mRNA] |
CTD |
PMID:30033591 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il5 |
interleukin 5 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [TNF protein results in decreased expression of IL5 mRNA] |
CTD |
PMID:31250491 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression decreases expression |
ISO EXP |
[lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in decreased expression of IL6 mRNA; [Rotenone co-treated with Bilirubin] inhibits the reaction [Cannabidiol results in increased expression of IL6 mRNA]; Bilirubin inhibits the reaction [Cannabidiol results in increased expression of IL6 mRNA]; Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of IL6 mRNA]; Cannabidiol inhibits the reaction [APP alternative form results in increased expression of IL6 mRNA]; Cannabidiol inhibits the reaction [DMD gene mutant form results in increased expression of IL6 protein]; Cannabidiol inhibits the reaction [Haloperidol results in increased expression of IL6 mRNA]; Cannabidiol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL6 protein]; Cannabidiol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; Rotenone inhibits the reaction [Cannabidiol results in increased expression of IL6 mRNA] Cannabidiol inhibits the reaction [Hydrogen Peroxide results in increased expression of IL6 protein]; Cannabidiol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein] Cannabidiol results in increased expression of IL6 mRNA; Cannabidiol results in increased expression of IL6 protein Cannabidiol results in decreased expression of IL6 mRNA Cannabidiol inhibits the reaction [CpG ODN 2395 results in increased secretion of IL6 protein]; Cannabidiol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]; Cannabidiol inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]; Cannabidiol promotes the reaction [FSL-1 lipoprotein, synthetic results in decreased secretion of IL6 protein]; Cannabidiol promotes the reaction [Imiquimod results in increased secretion of IL6 protein] |
CTD |
PMID:19910459 PMID:21350020 PMID:21492165 PMID:27430346 PMID:30033591 PMID:30074247 PMID:30217539 PMID:30742662 PMID:30793820 PMID:31250491 PMID:32033040 PMID:32345916 PMID:33244087 PMID:34740670 PMID:36519830 More...
|
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il6r |
interleukin 6 receptor |
decreases expression multiple interactions |
ISO |
Cannabidiol results in decreased expression of IL6RA mRNA Cannabidiol inhibits the reaction [DMD gene mutant form results in increased expression of IL6RA mRNA] |
CTD |
PMID:30074247 PMID:30742662 |
|
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
|
|
G |
Il6st |
interleukin 6 cytokine family signal transducer |
decreases expression |
ISO |
Cannabidiol results in decreased expression of IL6ST mRNA |
CTD |
PMID:27932991 PMID:31801206 |
|
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
|
|
G |
Il7 |
interleukin 7 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [TNF protein results in increased expression of IL7 mRNA] |
CTD |
PMID:31250491 |
|
NCBI chr 2:94,235,219...94,280,075
Ensembl chr 2:94,234,766...94,280,075
|
|
G |
Ilf2 |
interleukin enhancer binding factor 2 |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of ILF2 protein |
CTD |
PMID:34122009 |
|
NCBI chr 2:175,951,002...175,971,193
Ensembl chr 2:175,952,186...175,971,337
|
|
G |
Ing4 |
inhibitor of growth family, member 4 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of ING4 mRNA |
CTD |
PMID:27932991 |
|
NCBI chr 4:157,841,882...157,850,519
Ensembl chr 4:157,841,951...157,850,265
|
|
G |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
decreases expression |
ISO |
Cannabidiol results in decreased expression of INPP5D mRNA |
CTD |
PMID:30742662 |
|
NCBI chr 9:88,287,680...88,392,748
Ensembl chr 9:88,287,677...88,392,746
|
|
G |
Ins1 |
insulin 1 |
multiple interactions increases secretion increases expression |
EXP |
Cannabidiol promotes the reaction [Glucose results in increased secretion of INS1 protein] Cannabidiol analog results in increased secretion of INS1 protein Cannabidiol results in increased expression of INS1 protein |
CTD |
PMID:30382123 PMID:32553926 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Insig1 |
insulin induced gene 1 |
multiple interactions |
ISO |
Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of INSIG1 mRNA] |
CTD |
PMID:30825431 |
|
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
|
|
G |
Ipo4 |
importin 4 |
increases expression |
ISO |
Cannabidiol results in increased expression of IPO4 mRNA |
CTD |
PMID:31052254 |
|
NCBI chr15:29,117,365...29,127,382
Ensembl chr15:29,117,365...29,127,285
|
|
G |
Ipo7 |
importin 7 |
multiple interactions |
ISO |
[Cuprizone co-treated with Cannabidiol] results in decreased expression of IPO7 protein |
CTD |
PMID:34122009 |
|
NCBI chr 1:164,062,702...164,102,938
Ensembl chr 1:164,062,702...164,102,938
|
|
G |
Ipo8 |
importin 8 |
decreases expression |
ISO |
Cannabidiol results in decreased expression of IPO8 mRNA |
CTD |
PMID:31052254 |
|
NCBI chr 4:181,729,216...181,793,673
Ensembl chr 4:181,729,220...181,793,161
|
|
G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
multiple interactions |
ISO |
Cannabidiol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased degradation of IRAK1 protein] |
CTD |
PMID:19910459 |
|
NCBI chr X:151,768,621...151,778,521
Ensembl chr X:151,768,777...151,778,521
|
|
G |
Irak3 |
interleukin-1 receptor-associated kinase 3 |
multiple interactions |
ISO |
[lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in decreased expression of IRAK3 mRNA |
CTD |
PMID:30742662 |
|
NCBI chr 7:55,653,949...55,714,371
Ensembl chr 7:55,653,962...55,713,121
|
|
G |
Irf3 |
interferon regulatory factor 3 |
multiple interactions |
ISO |
[Dronabinol co-treated with Cannabidiol] inhibits the reaction [Poly I-C affects the localization of IRF3 protein]; Cannabidiol inhibits the reaction [Poly I-C affects the localization of IRF3 protein] |
CTD |
PMID:32244040 |
|
NCBI chr 1:95,479,966...95,484,926
Ensembl chr 1:95,479,821...95,484,935
|
![JBrowse link]() |